data_1z3r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z3r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.409 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.404 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' A' ' 98' ' ' LYS . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.401 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' H ' HG21 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.464 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.0 103.73 0.16 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.135 2.174 . . . . 0.0 113.423 -169.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -65.05 102.33 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 110.868 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 87.07 1.44 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -167.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.78 -27.31 2.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.968 1.307 . . . . 0.0 113.791 165.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.43 128.66 54.82 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -135.73 172.4 13.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.589 1.555 . . . . 0.0 110.07 -157.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.9 -3.83 44.62 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -133.69 42.19 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.906 2.082 . . . . 0.0 110.721 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.57 -150.3 18.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.666 1.603 . . . . 0.0 110.918 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.14 175.45 46.49 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.3 mm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.9 p -40.74 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.27 2.628 . . . . 0.0 116.711 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -72.74 46.86 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.022 1.729 . . . . 0.0 111.728 165.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.69 120.23 17.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 128.009 2.718 . . . . 0.0 115.2 -168.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.43 -13.17 61.79 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.521 1.528 . . . . 0.0 113.499 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.98 128.96 55.71 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -136.28 167.07 22.0 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.784 1.278 . . . . 0.0 112.939 -159.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.37 -8.65 59.37 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.254 1.821 . . . . 0.0 112.517 165.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.8 24.26 5.72 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.518 1.927 . . . . 0.0 112.28 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.67 -152.6 24.66 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.651 1.595 . . . . 0.0 111.986 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.89 174.86 21.5 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 159.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.749 -0.643 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -59.22 119.63 7.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 111.224 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' CA ' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -77.29 53.35 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.297 1.039 . . . . 0.0 110.879 174.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.65 -166.64 12.27 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.213 1.387 . . . . 0.0 115.419 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp 68.02 -45.59 0.51 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 130.836 3.654 . . . . 0.0 114.318 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.409 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.51 125.5 52.01 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -138.24 176.76 8.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.68 1.592 . . . . 0.0 110.088 -161.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -93.12 -47.21 7.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.053 1.341 . . . . 0.0 110.354 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.8 27.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.118 2.567 . . . . 0.0 115.161 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.46 -149.61 18.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.362 1.458 . . . . 0.0 111.778 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.53 173.35 29.59 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -58.25 140.12 53.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.74 0.781 . . . . 0.0 112.116 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -80.85 59.25 3.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.906 1.683 . . . . 0.0 110.69 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.87 97.68 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 C-N-CA 130.697 3.998 . . . . 0.0 116.978 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.22 -22.14 62.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.402 1.481 . . . . 0.0 113.444 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 110.92 12.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.14 170.03 8.67 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.958 0.885 . . . . 0.0 111.313 -170.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -84.15 -2.74 57.35 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.753 0.821 . . . . 0.0 112.339 163.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.62 22.73 4.31 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.098 2.159 . . . . 0.0 112.203 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.19 -166.47 28.99 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.406 1.479 . . . . 0.0 112.696 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.23 -176.12 30.11 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 170.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p -136.16 -172.79 3.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.754 0.822 . . . . 0.0 111.418 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -133.86 88.35 2.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.338 1.455 . . . . 0.0 109.567 167.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -66.17 83.9 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.327 0.965 . . . . 0.0 115.005 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.47 -15.89 3.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.887 1.675 . . . . 0.0 113.709 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.512 ' CE2' ' HA3' ' A' ' 4' ' ' GLY . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.47 112.16 23.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -116.53 168.1 10.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 0.0 109.94 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -77.84 -10.99 59.84 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.032 -1.043 . . . . 0.0 113.026 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -128.13 12.14 6.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.254 1.822 . . . . 0.0 112.753 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.55 -169.67 35.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.235 1.874 . . . . 0.0 111.488 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.66 -175.78 18.3 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -39.27 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.504 2.722 . . . . 0.0 117.304 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -78.28 56.87 1.77 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.423 -1.423 . . . . 0.0 110.465 164.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.27 118.2 13.92 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.636 2.065 . . . . 0.0 115.177 -166.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.55 -11.53 7.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.903 1.281 . . . . 0.0 113.777 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.85 125.42 50.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.97 176.85 7.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.369 1.468 . . . . 0.0 110.499 -165.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -93.52 -29.92 15.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.892 1.277 . . . . 0.0 111.862 165.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -100.7 36.87 1.82 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.051 2.14 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -149.59 19.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.256 1.408 . . . . 0.0 111.994 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.18 176.12 31.71 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 165.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.9 p -68.44 93.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.892 1.677 . . . . 0.0 113.318 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -72.22 48.7 0.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.118 1.767 . . . . 0.0 111.759 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.9 103.35 0.16 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 128.321 2.867 . . . . 0.0 116.482 -168.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -58.61 -13.34 5.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.675 1.59 . . . . 0.0 114.06 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.413 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.5 129.74 50.74 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -138.71 167.66 21.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.329 1.062 . . . . 0.0 112.152 -166.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -85.3 -12.88 51.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.935 2.094 . . . . 0.0 113.076 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -122.58 24.59 9.14 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.702 2.001 . . . . 0.0 111.429 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.16 -140.78 12.0 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.24 1.876 . . . . 0.0 111.11 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.14 -173.41 55.16 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 4' ' ' GLY . 98.3 p -68.52 102.62 1.49 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.315 2.246 . . . . 0.0 113.471 -175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HE2' ' N ' ' A' ' 3' ' ' LYS . 2.6 mmpt? -75.11 29.57 0.09 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.507 -1.371 . . . . 0.0 113.171 172.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 2' ' ' SER . . . 2.62 79.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.754 1 C-N-CA 132.106 4.67 . . . . 0.0 118.317 170.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.85 -20.56 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.099 1.36 . . . . 0.0 112.217 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.427 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 135.03 54.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -140.75 172.18 13.06 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.946 0.879 . . . . 0.0 111.851 -161.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -90.8 -7.08 53.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.529 1.531 . . . . 0.0 112.709 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -129.91 28.51 5.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.776 2.03 . . . . 0.0 111.629 -173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -145.8 17.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.714 1.626 . . . . 0.0 111.13 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.52 175.86 44.54 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 122.293 1.044 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 98.4 p -148.02 92.12 2.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.056 1.742 . . . . 0.0 109.174 -164.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.65 56.85 1.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.538 1.161 . . . . 0.0 109.968 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.28 0.1 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 128.773 3.083 . . . . 0.0 113.104 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt -55.55 -13.42 1.55 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.239 1.816 . . . . 0.0 113.782 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 142.32 35.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 2' ' ' SER . 32.3 mt-10 -144.96 172.54 12.9 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.375 1.07 . . . . 0.0 110.571 -160.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -94.66 -16.98 22.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.968 1.307 . . . . 0.0 112.715 166.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -115.8 27.91 8.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.602 1.961 . . . . 0.0 111.5 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.31 -148.89 20.87 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.739 2.114 . . . . 0.0 109.86 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.83 163.15 26.91 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 160.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -54.17 103.97 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.157 1.783 . . . . 0.0 113.146 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -56.78 114.85 2.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.926 2.091 . . . . 0.0 110.129 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.8 88.99 1.58 Allowed Glycine 0 N--CA 1.462 0.412 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -165.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.9 -18.55 13.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 0.0 112.768 168.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.32 120.62 34.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -128.85 161.01 30.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.856 0.836 . . . . 0.0 111.179 -155.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -81.63 -3.69 54.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.721 0.808 . . . . 0.0 112.124 168.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -130.02 24.81 5.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.082 2.153 . . . . 0.0 111.984 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.21 -145.23 16.36 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.965 1.269 . . . . 0.0 112.608 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.04 -176.68 42.5 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 166.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 mm . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m -55.33 145.98 20.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.518 1.127 . . . . 0.0 113.905 -171.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -106.61 95.98 6.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.021 1.329 . . . . 0.0 110.272 -173.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -77.83 88.13 1.06 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.531 1.062 . . . . 0.0 114.82 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt -55.58 -20.16 12.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.154 1.382 . . . . 0.0 113.138 164.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' A' ' 98' ' ' LYS . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 127.7 51.87 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.71 159.45 30.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.083 1.353 . . . . 0.0 110.642 -162.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -73.91 -10.25 59.46 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.954 -1.091 . . . . 0.0 112.895 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -131.34 33.46 4.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.035 2.134 . . . . 0.0 112.185 -174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.52 -152.44 23.4 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.507 1.051 . . . . 0.0 112.287 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.29 178.34 30.11 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 168.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.497 ' HA ' ' OE1' ' A' ' 68' ' ' GLU 0.276 14.6 tt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.813 0.339 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t 59.94 -164.91 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.095 2.558 . . . . 0.0 116.102 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -84.21 74.18 10.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.266 2.226 . . . . 0.0 111.944 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.27 124.47 6.67 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.524 1.059 . . . . 0.0 113.246 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.7 -11.58 27.12 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.552 1.541 . . . . 0.0 113.529 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.401 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.18 117.98 35.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 1' ' ' ILE . 3.7 tp10 -103.29 158.42 16.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 110.589 -160.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -57.37 -21.91 39.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.38 26.88 1.28 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.022 0.929 . . . . 0.0 112.172 175.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.0 -157.93 19.15 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.342 -0.848 . . . . 0.0 113.755 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.9 -170.57 32.1 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 168.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' H ' HG21 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -49.7 95.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.229 1.812 . . . . 0.0 115.393 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -74.23 56.69 0.64 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.076 -1.64 . . . . 0.0 110.068 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.23 118.71 12.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 127.63 2.538 . . . . 0.0 114.132 -167.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.78 -6.76 6.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.453 1.501 . . . . 0.0 113.989 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.19 125.48 51.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.47 163.52 29.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.293 1.044 . . . . 0.0 112.82 -157.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -74.71 -13.13 60.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.548 1.539 . . . . 0.0 113.39 163.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -125.33 25.97 6.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.379 1.871 . . . . 0.0 112.031 -172.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.78 -141.88 13.32 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.475 1.512 . . . . 0.0 111.646 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -177.65 39.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 167.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -46.11 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.18 2.592 . . . . 0.0 116.227 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -75.63 32.88 0.11 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.469 1.908 . . . . 0.0 113.141 170.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -43.68 113.47 0.74 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.893 3.139 . . . . 0.0 115.929 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.24 -7.19 5.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.626 1.57 . . . . 0.0 114.209 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.464 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.61 137.76 53.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -145.78 -177.15 5.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.982 1.313 . . . . 0.0 110.333 -156.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -100.25 -35.7 9.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.192 1.797 . . . . 0.0 111.67 165.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -89.2 33.49 0.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 112.105 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.81 -145.14 15.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.541 1.543 . . . . 0.0 111.185 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.99 169.8 38.17 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.422 ' HA ' ' OE2' ' A' ' 68' ' ' GLU . 6.5 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.749 0.309 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 50.19 -151.88 0.18 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.783 1.633 . . . . 0.0 114.414 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -65.14 28.99 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 131.058 3.743 . . . . 0.0 115.19 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.73 100.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.645 3.497 . . . . 0.0 116.545 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp -55.57 -18.94 8.59 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.1 2.16 . . . . 0.0 114.233 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.97 113.39 26.54 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' OE2' ' HA ' ' A' ' 1' ' ' ILE . 12.8 tp10 -116.86 154.89 29.97 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.904 1.682 . . . . 0.0 110.472 -156.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.39 -27.56 66.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.67 34.81 2.01 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 110.746 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.61 -167.08 40.25 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.41 -0.806 . . . . 0.0 113.796 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.81 -173.35 29.32 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 164.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 88' ' ' VAL . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CG2' HG13 ' A' ' 88' ' ' VAL . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.441 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' H ' HG22 ' A' ' 62' ' ' THR . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.589 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 33' ' ' VAL . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 79' ' ' LEU . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 45' ' ' VAL . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 43' ' ' ILE . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 45' ' ' VAL . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 79' ' ' LEU . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG11 HG11 ' A' ' 33' ' ' VAL . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.451 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 88' ' ' VAL . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 HD13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.739 HD13 HG21 ' A' ' 45' ' ' VAL . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 33' ' ' VAL . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.465 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.458 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.584 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 79' ' ' LEU . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 88' ' ' VAL . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG13 ' A' ' 88' ' ' VAL . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 79' ' ' LEU . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 45' ' ' VAL . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 29' ' ' VAL . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 33' ' ' VAL . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 88' ' ' VAL . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 45' ' ' VAL . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.455 ' CD1' HG21 ' A' ' 45' ' ' VAL . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 62' ' ' THR . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.657 ' C ' HD12 ' A' ' 79' ' ' LEU . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.578 HG21 HG11 ' A' ' 33' ' ' VAL . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 45' ' ' VAL . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 43' ' ' ILE . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 45' ' ' VAL . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.582 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 79' ' ' LEU . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.427 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 88' ' ' VAL . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 45' ' ' VAL . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 45' ' ' VAL . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.537 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 33' ' ' VAL . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 79' ' ' LEU . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.418 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 45' ' ' VAL . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' CD1' HG21 ' A' ' 45' ' ' VAL . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' H ' HG22 ' A' ' 62' ' ' THR . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.625 ' C ' HD12 ' A' ' 79' ' ' LEU . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 66' ' ' THR . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.444 ' CG2' HG22 ' A' ' 88' ' ' VAL . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 42' ' ' ARG . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 62' ' ' THR . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 79' ' ' LEU . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.626 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 45' ' ' VAL . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 79' ' ' LEU . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.485 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 45' ' ' VAL . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' ALA . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 45' ' ' VAL . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 62' ' ' THR . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 33' ' ' VAL . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 88' ' ' VAL . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.639 HG22 HG23 ' A' ' 45' ' ' VAL . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 43' ' ' ILE . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 HG21 ' A' ' 45' ' ' VAL . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.69 ' H ' HG22 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.554 ' C ' HD12 ' A' ' 79' ' ' LEU . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.554 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 62' ' ' THR . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.612 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG21 HG11 ' A' ' 33' ' ' VAL . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 88' ' ' VAL . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 88' ' ' VAL . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 45' ' ' VAL . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 62' ' ' THR . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.531 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 33' ' ' VAL . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 79' ' ' LEU . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.407 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 62' ' ' THR . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 79' ' ' LEU . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.567 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 45' ' ' VAL . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.0 103.73 0.16 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.135 2.174 . . . . 0.0 113.423 -169.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -65.05 102.33 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 110.868 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 87.07 1.44 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -167.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.78 -27.31 2.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.968 1.307 . . . . 0.0 113.791 165.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 88' ' ' VAL . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CG2' HG13 ' A' ' 88' ' ' VAL . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.43 128.66 54.82 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -135.73 172.4 13.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.589 1.555 . . . . 0.0 110.07 -157.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.9 -3.83 44.62 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -133.69 42.19 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.906 2.082 . . . . 0.0 110.721 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.57 -150.3 18.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.666 1.603 . . . . 0.0 110.918 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.14 175.45 46.49 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.441 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' H ' HG22 ' A' ' 62' ' ' THR . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.589 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 33' ' ' VAL . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.3 mm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.9 p -40.74 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.27 2.628 . . . . 0.0 116.711 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -72.74 46.86 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.022 1.729 . . . . 0.0 111.728 165.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.69 120.23 17.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 128.009 2.718 . . . . 0.0 115.2 -168.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.43 -13.17 61.79 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.521 1.528 . . . . 0.0 113.499 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 79' ' ' LEU . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 45' ' ' VAL . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 43' ' ' ILE . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.98 128.96 55.71 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -136.28 167.07 22.0 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.784 1.278 . . . . 0.0 112.939 -159.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.37 -8.65 59.37 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.254 1.821 . . . . 0.0 112.517 165.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.8 24.26 5.72 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.518 1.927 . . . . 0.0 112.28 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.67 -152.6 24.66 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.651 1.595 . . . . 0.0 111.986 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.89 174.86 21.5 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 159.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 45' ' ' VAL . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 79' ' ' LEU . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG11 HG11 ' A' ' 33' ' ' VAL . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.749 -0.643 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -59.22 119.63 7.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 111.224 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.29 53.35 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.297 1.039 . . . . 0.0 110.879 174.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.65 -166.64 12.27 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.213 1.387 . . . . 0.0 115.419 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp 68.02 -45.59 0.51 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 130.836 3.654 . . . . 0.0 114.318 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.451 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 88' ' ' VAL . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 HD13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.51 125.5 52.01 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -138.24 176.76 8.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.68 1.592 . . . . 0.0 110.088 -161.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -93.12 -47.21 7.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.053 1.341 . . . . 0.0 110.354 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.8 27.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.118 2.567 . . . . 0.0 115.161 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.46 -149.61 18.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.362 1.458 . . . . 0.0 111.778 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.53 173.35 29.59 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.739 HD13 HG21 ' A' ' 45' ' ' VAL . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 33' ' ' VAL . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -58.25 140.12 53.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.74 0.781 . . . . 0.0 112.116 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -80.85 59.25 3.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.906 1.683 . . . . 0.0 110.69 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.87 97.68 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 C-N-CA 130.697 3.998 . . . . 0.0 116.978 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.22 -22.14 62.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.402 1.481 . . . . 0.0 113.444 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.465 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 110.92 12.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.14 170.03 8.67 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.958 0.885 . . . . 0.0 111.313 -170.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -84.15 -2.74 57.35 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.753 0.821 . . . . 0.0 112.339 163.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.62 22.73 4.31 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.098 2.159 . . . . 0.0 112.203 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.19 -166.47 28.99 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.406 1.479 . . . . 0.0 112.696 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.23 -176.12 30.11 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 170.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.458 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.584 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p -136.16 -172.79 3.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.754 0.822 . . . . 0.0 111.418 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -133.86 88.35 2.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.338 1.455 . . . . 0.0 109.567 167.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -66.17 83.9 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.327 0.965 . . . . 0.0 115.005 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.47 -15.89 3.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.887 1.675 . . . . 0.0 113.709 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.54 ' CE2' ' HA3' ' A' ' 4' ' ' GLY . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 79' ' ' LEU . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 88' ' ' VAL . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG13 ' A' ' 88' ' ' VAL . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 79' ' ' LEU . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.47 112.16 23.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -116.53 168.1 10.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 0.0 109.94 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -77.84 -10.99 59.84 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.032 -1.043 . . . . 0.0 113.026 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -128.13 12.14 6.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.254 1.822 . . . . 0.0 112.753 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.55 -169.67 35.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.235 1.874 . . . . 0.0 111.488 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.66 -175.78 18.3 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 45' ' ' VAL . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 29' ' ' VAL . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 33' ' ' VAL . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -39.27 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.504 2.722 . . . . 0.0 117.304 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -78.28 56.87 1.77 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.423 -1.423 . . . . 0.0 110.465 164.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.27 118.2 13.92 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.636 2.065 . . . . 0.0 115.177 -166.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.55 -11.53 7.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.903 1.281 . . . . 0.0 113.777 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 88' ' ' VAL . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 45' ' ' VAL . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.85 125.42 50.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.97 176.85 7.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.369 1.468 . . . . 0.0 110.499 -165.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -93.52 -29.92 15.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.892 1.277 . . . . 0.0 111.862 165.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -100.7 36.87 1.82 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.051 2.14 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -149.59 19.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.256 1.408 . . . . 0.0 111.994 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.18 176.12 31.71 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 165.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.455 ' CD1' HG21 ' A' ' 45' ' ' VAL . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 62' ' ' THR . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.657 ' C ' HD12 ' A' ' 79' ' ' LEU . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG21 HG11 ' A' ' 33' ' ' VAL . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.9 p -68.44 93.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.892 1.677 . . . . 0.0 113.318 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -72.22 48.7 0.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.118 1.767 . . . . 0.0 111.759 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.9 103.35 0.16 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 128.321 2.867 . . . . 0.0 116.482 -168.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -58.61 -13.34 5.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.675 1.59 . . . . 0.0 114.06 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 45' ' ' VAL . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 43' ' ' ILE . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.5 129.74 50.74 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -138.71 167.66 21.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.329 1.062 . . . . 0.0 112.152 -166.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -85.3 -12.88 51.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.935 2.094 . . . . 0.0 113.076 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -122.58 24.59 9.14 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.702 2.001 . . . . 0.0 111.429 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.16 -140.78 12.0 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.24 1.876 . . . . 0.0 111.11 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.14 -173.41 55.16 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 45' ' ' VAL . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.582 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.3 p -68.52 102.62 1.49 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.315 2.246 . . . . 0.0 113.471 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -75.11 29.57 0.09 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.507 -1.371 . . . . 0.0 113.171 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 7' ' ' TYR . . . 2.62 79.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.754 1 C-N-CA 132.106 4.67 . . . . 0.0 118.317 170.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.85 -20.56 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.099 1.36 . . . . 0.0 112.217 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 79' ' ' LEU . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.427 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 88' ' ' VAL . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 45' ' ' VAL . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 135.03 54.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -140.75 172.18 13.06 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.946 0.879 . . . . 0.0 111.851 -161.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -90.8 -7.08 53.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.529 1.531 . . . . 0.0 112.709 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -129.91 28.51 5.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.776 2.03 . . . . 0.0 111.629 -173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -145.8 17.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.714 1.626 . . . . 0.0 111.13 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.52 175.86 44.54 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 45' ' ' VAL . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.537 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 33' ' ' VAL . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 122.293 1.044 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.4 p -148.02 92.12 2.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.056 1.742 . . . . 0.0 109.174 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.65 56.85 1.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.538 1.161 . . . . 0.0 109.968 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.28 0.1 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 128.773 3.083 . . . . 0.0 113.104 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt -55.55 -13.42 1.55 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.239 1.816 . . . . 0.0 113.782 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 79' ' ' LEU . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.418 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 45' ' ' VAL . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 142.32 35.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -144.96 172.54 12.9 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.375 1.07 . . . . 0.0 110.571 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -94.66 -16.98 22.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.968 1.307 . . . . 0.0 112.715 166.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -115.8 27.91 8.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.602 1.961 . . . . 0.0 111.5 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.31 -148.89 20.87 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.739 2.114 . . . . 0.0 109.86 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.83 163.15 26.91 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 160.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' CD1' HG21 ' A' ' 45' ' ' VAL . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' H ' HG22 ' A' ' 62' ' ' THR . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.625 ' C ' HD12 ' A' ' 79' ' ' LEU . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -54.17 103.97 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.157 1.783 . . . . 0.0 113.146 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -56.78 114.85 2.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.926 2.091 . . . . 0.0 110.129 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.8 88.99 1.58 Allowed Glycine 0 N--CA 1.462 0.412 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -165.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.9 -18.55 13.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 0.0 112.768 168.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 66' ' ' THR . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.444 ' CG2' HG22 ' A' ' 88' ' ' VAL . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 42' ' ' ARG . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.32 120.62 34.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -128.85 161.01 30.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.856 0.836 . . . . 0.0 111.179 -155.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -81.63 -3.69 54.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.721 0.808 . . . . 0.0 112.124 168.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -130.02 24.81 5.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.082 2.153 . . . . 0.0 111.984 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.21 -145.23 16.36 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.965 1.269 . . . . 0.0 112.608 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.04 -176.68 42.5 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 166.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 62' ' ' THR . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 79' ' ' LEU . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.626 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 45' ' ' VAL . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 mm . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m -55.33 145.98 20.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.518 1.127 . . . . 0.0 113.905 -171.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -106.61 95.98 6.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.021 1.329 . . . . 0.0 110.272 -173.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -77.83 88.13 1.06 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.531 1.062 . . . . 0.0 114.82 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt -55.58 -20.16 12.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.154 1.382 . . . . 0.0 113.138 164.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 79' ' ' LEU . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.485 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 45' ' ' VAL . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' ALA . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 4' ' ' GLY . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 127.7 51.87 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.71 159.45 30.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.083 1.353 . . . . 0.0 110.642 -162.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -73.91 -10.25 59.46 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.954 -1.091 . . . . 0.0 112.895 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -131.34 33.46 4.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.035 2.134 . . . . 0.0 112.185 -174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.52 -152.44 23.4 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.507 1.051 . . . . 0.0 112.287 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.29 178.34 30.11 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 168.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 45' ' ' VAL . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 62' ' ' THR . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 33' ' ' VAL . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.489 ' HA ' ' OE1' ' A' ' 68' ' ' GLU 0.276 14.6 tt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.813 0.339 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t 59.94 -164.91 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.095 2.558 . . . . 0.0 116.102 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -84.21 74.18 10.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.266 2.226 . . . . 0.0 111.944 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.27 124.47 6.67 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.524 1.059 . . . . 0.0 113.246 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.7 -11.58 27.12 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.552 1.541 . . . . 0.0 113.529 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 88' ' ' VAL . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.639 HG22 HG23 ' A' ' 45' ' ' VAL . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 43' ' ' ILE . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.18 117.98 35.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 1' ' ' ILE . 3.7 tp10 -103.29 158.42 16.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 110.589 -160.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -57.37 -21.91 39.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.38 26.88 1.28 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.022 0.929 . . . . 0.0 112.172 175.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.0 -157.93 19.15 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.342 -0.848 . . . . 0.0 113.755 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.9 -170.57 32.1 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 168.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 HG21 ' A' ' 45' ' ' VAL . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.69 ' H ' HG22 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' C ' HD12 ' A' ' 79' ' ' LEU . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.554 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -49.7 95.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.229 1.812 . . . . 0.0 115.393 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -74.23 56.69 0.64 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.076 -1.64 . . . . 0.0 110.068 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.23 118.71 12.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 127.63 2.538 . . . . 0.0 114.132 -167.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.78 -6.76 6.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.453 1.501 . . . . 0.0 113.989 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.19 125.48 51.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.47 163.52 29.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.293 1.044 . . . . 0.0 112.82 -157.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -74.71 -13.13 60.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.548 1.539 . . . . 0.0 113.39 163.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -125.33 25.97 6.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.379 1.871 . . . . 0.0 112.031 -172.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.78 -141.88 13.32 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.475 1.512 . . . . 0.0 111.646 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -177.65 39.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 167.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 62' ' ' THR . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.612 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG21 HG11 ' A' ' 33' ' ' VAL . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -46.11 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.18 2.592 . . . . 0.0 116.227 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -75.63 32.88 0.11 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.469 1.908 . . . . 0.0 113.141 170.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -43.68 113.47 0.74 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.893 3.139 . . . . 0.0 115.929 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.24 -7.19 5.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.626 1.57 . . . . 0.0 114.209 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 88' ' ' VAL . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 88' ' ' VAL . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.61 137.76 53.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -145.78 -177.15 5.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.982 1.313 . . . . 0.0 110.333 -156.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -100.25 -35.7 9.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.192 1.797 . . . . 0.0 111.67 165.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -89.2 33.49 0.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 112.105 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.81 -145.14 15.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.541 1.543 . . . . 0.0 111.185 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.99 169.8 38.17 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 45' ' ' VAL . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 62' ' ' THR . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.531 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 33' ' ' VAL . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.749 0.309 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 50.19 -151.88 0.18 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.783 1.633 . . . . 0.0 114.414 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -65.14 28.99 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 131.058 3.743 . . . . 0.0 115.19 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.73 100.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.645 3.497 . . . . 0.0 116.545 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp -55.57 -18.94 8.59 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.1 2.16 . . . . 0.0 114.233 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 79' ' ' LEU . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.407 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.97 113.39 26.54 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.86 154.89 29.97 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.904 1.682 . . . . 0.0 110.472 -156.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.39 -27.56 66.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.67 34.81 2.01 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 110.746 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.61 -167.08 40.25 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.41 -0.806 . . . . 0.0 113.796 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.81 -173.35 29.32 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 164.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 62' ' ' THR . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 79' ' ' LEU . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.567 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 45' ' ' VAL . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 88' ' ' VAL . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CG2' HG13 ' A' ' 88' ' ' VAL . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.441 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.433 ' H ' HG22 ' A' ' 62' ' ' THR . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.589 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 33' ' ' VAL . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 79' ' ' LEU . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 45' ' ' VAL . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 43' ' ' ILE . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 45' ' ' VAL . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 79' ' ' LEU . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG11 HG11 ' A' ' 33' ' ' VAL . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.451 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 88' ' ' VAL . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 HD13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.739 HD13 HG21 ' A' ' 45' ' ' VAL . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 33' ' ' VAL . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.465 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.458 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.584 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 79' ' ' LEU . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 88' ' ' VAL . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG13 ' A' ' 88' ' ' VAL . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 79' ' ' LEU . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 45' ' ' VAL . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 29' ' ' VAL . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 33' ' ' VAL . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 88' ' ' VAL . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 45' ' ' VAL . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.455 ' CD1' HG21 ' A' ' 45' ' ' VAL . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 62' ' ' THR . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.657 ' C ' HD12 ' A' ' 79' ' ' LEU . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.578 HG21 HG11 ' A' ' 33' ' ' VAL . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 45' ' ' VAL . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 43' ' ' ILE . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 45' ' ' VAL . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.582 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 79' ' ' LEU . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.427 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 88' ' ' VAL . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 45' ' ' VAL . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 45' ' ' VAL . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.537 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 33' ' ' VAL . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 79' ' ' LEU . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.418 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 45' ' ' VAL . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.456 ' CD1' HG21 ' A' ' 45' ' ' VAL . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' H ' HG22 ' A' ' 62' ' ' THR . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.625 ' C ' HD12 ' A' ' 79' ' ' LEU . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 66' ' ' THR . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.444 ' CG2' HG22 ' A' ' 88' ' ' VAL . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 42' ' ' ARG . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 62' ' ' THR . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 79' ' ' LEU . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.626 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 45' ' ' VAL . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 79' ' ' LEU . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.485 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 45' ' ' VAL . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' ALA . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 45' ' ' VAL . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 62' ' ' THR . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 33' ' ' VAL . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 88' ' ' VAL . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.639 HG22 HG23 ' A' ' 45' ' ' VAL . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 43' ' ' ILE . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 HG21 ' A' ' 45' ' ' VAL . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.69 ' H ' HG22 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.554 ' C ' HD12 ' A' ' 79' ' ' LEU . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.554 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 62' ' ' THR . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.612 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG21 HG11 ' A' ' 33' ' ' VAL . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 88' ' ' VAL . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 88' ' ' VAL . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 45' ' ' VAL . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 62' ' ' THR . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.531 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 33' ' ' VAL . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 79' ' ' LEU . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.407 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 62' ' ' THR . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 79' ' ' LEU . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.567 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 45' ' ' VAL . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.0 103.73 0.16 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.135 2.174 . . . . 0.0 113.423 -169.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -65.05 102.33 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 110.868 178.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 87.07 1.44 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -167.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 mt -48.78 -27.31 2.88 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.968 1.307 . . . . 0.0 113.791 165.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.0 p -112.37 -1.98 14.91 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.766 1.626 . . . . 0.0 114.3 -173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -68.92 147.46 51.63 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.267 1.394 . . . . 0.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -66.41 154.41 40.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.992 1.317 . . . . 0.0 111.197 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 mmt -66.22 147.61 53.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.441 0.697 . . . . 0.0 112.649 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 39.5 m -76.12 157.82 32.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.753 0.821 . . . . 0.0 112.49 170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -63.05 127.44 31.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.14 1.776 . . . . 0.0 111.418 170.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -61.0 -21.06 63.21 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.34 -8.66 14.68 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -169.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -93.0 12.49 23.81 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -93.61 155.6 17.19 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.928 1.291 . . . . 0.0 114.261 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -142.32 146.1 34.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.07 2.148 . . . . 0.0 109.333 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -74.77 110.06 8.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.969 0.907 . . . . 0.0 110.92 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -74.08 -33.33 63.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.801 0.84 . . . . 0.0 110.492 165.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -150.41 112.63 4.62 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.688 2.795 . . . . 0.0 107.898 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 153.29 47.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.021 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.12 121.42 6.83 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.946 3.098 . . . . 0.0 113.505 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -144.21 170.03 16.74 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.103 0.961 . . . . 0.0 111.589 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.21 139.55 39.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.494 0.718 . . . . 0.0 110.854 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -72.14 -3.75 25.1 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.296 1.438 . . . . 0.0 114.777 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.68 86.83 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.604 1.097 . . . . 0.0 112.648 -164.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -133.76 22.1 3.9 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.799 1.64 . . . . 0.0 112.291 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 69.79 9.3 7.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.941 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -104.08 161.46 13.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.318 1.847 . . . . 0.0 109.229 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.2 t -117.58 109.16 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.381 1.872 . . . . 0.0 108.559 -166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.1 m -95.49 144.74 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.555 1.142 . . . . 0.0 110.027 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.441 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 6.7 ptp -150.82 169.09 22.53 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.538 0.735 . . . . 0.0 110.097 168.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -151.84 144.2 24.07 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.602 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 88' ' ' VAL . 29.2 m -130.15 164.31 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.9 51.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.313 2.245 . . . . 0.0 108.687 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 65.9 t80 -142.41 129.52 20.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -155.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -92.01 -0.84 57.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.84 -163.23 33.77 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 119.345 0.975 . . . . 0.0 113.632 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.41 143.6 3.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.547 2.339 . . . . 0.0 114.729 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -121.93 120.7 28.35 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.102 1.361 . . . . 0.0 108.102 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.56 169.47 68.43 Favored 'Cis proline' 0 CA--C 1.54 0.812 0 CA-C-N 120.008 1.039 . . . . 0.0 112.739 0.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.15 162.85 40.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.167 0.587 . . . . 0.0 112.199 157.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -89.11 128.83 35.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.867 2.067 . . . . 0.0 110.622 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CG2' HG13 ' A' ' 88' ' ' VAL . 36.9 mt -71.51 119.92 76.77 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.623 0.769 . . . . 0.0 109.688 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.16 68.53 3.29 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.633 3.556 . . . . 0.0 110.187 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.59 152.53 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.767 1.227 . . . . 0.0 111.04 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -167.19 158.36 11.96 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.003 1.721 . . . . 0.0 109.474 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.69 116.5 23.17 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.86 1.264 . . . . 0.0 108.73 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 m -114.22 117.04 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.61 0.641 . . . . 0.0 110.301 -170.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.96 154.66 41.67 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -48.55 99.82 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.326 1.85 . . . . 0.0 113.582 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.282 1.42 . . . . 0.0 115.179 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.52 78.54 43.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.522 1.661 . . . . 0.0 111.658 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.13 -11.41 31.95 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.502 2.801 . . . . 0.0 114.248 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.74 -27.09 40.57 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.379 2.272 . . . . 0.0 113.354 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.8 t -103.24 107.66 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.399 0.68 . . . . 0.0 110.974 -163.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.11 123.18 19.17 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.804 0.335 . . . . 0.0 111.379 166.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -105.98 3.4 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.465 1.906 . . . . 0.0 112.865 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.17 114.56 8.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.328 1.051 . . . . 0.0 113.481 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 tpt -91.61 101.18 13.82 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 161.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.35 129.89 42.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.549 0.74 . . . . 0.0 112.194 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mm -93.88 -40.6 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.634 1.574 . . . . 0.0 110.129 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -85.61 163.64 43.41 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.306 0.642 . . . . 0.0 109.834 167.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.53 168.07 4.4 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.696 2.264 . . . . 0.0 114.794 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -34.18 101.98 0.21 Allowed Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 128.102 2.561 . . . . 0.0 111.742 161.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.68 145.35 18.15 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.402 2.068 . . . . 0.0 113.1 -163.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.4 p -134.25 156.78 47.8 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.973 1.309 . . . . 0.0 111.759 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.43 128.66 54.82 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.767 1.627 . . . . 0.0 108.223 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -135.73 172.4 13.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.589 1.555 . . . . 0.0 110.07 -157.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.9 -3.83 44.62 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -133.69 42.19 2.98 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.906 2.082 . . . . 0.0 110.721 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.57 -150.3 18.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.666 1.603 . . . . 0.0 110.918 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.14 175.45 46.49 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 122.736 1.187 . . . . 0.0 114.262 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.95 -9.23 75.29 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.487 -1.729 . . . . 0.0 114.742 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -91.88 143.93 26.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.952 1.876 . . . . 0.0 112.988 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.441 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 7.0 mt -147.07 140.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.415 1.486 . . . . 0.0 109.177 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' H ' HG22 ' A' ' 62' ' ' THR . 63.2 tt0 -135.55 135.49 40.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.477 1.111 . . . . 0.0 110.246 163.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.2 ptp -144.71 166.43 25.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.486 1.914 . . . . 0.0 111.163 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.589 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.8 tt0 -124.5 148.15 47.91 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.695 1.198 . . . . 0.0 110.683 170.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.589 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.3 mp -142.43 158.61 60.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 126.222 1.809 . . . . 0.0 110.302 -163.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.42 129.23 16.57 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.667 2.912 . . . . 0.0 111.327 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.76 127.38 11.92 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.742 3.628 . . . . 0.0 113.438 170.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.53 179.02 16.47 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.287 0.946 . . . . 0.0 112.365 -167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -74.77 117.94 17.17 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.285 1.034 . . . . 0.0 111.199 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -127.81 126.32 41.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.458 1.503 . . . . 0.0 109.649 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.31 105.95 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.8 mt -94.37 116.51 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -102.76 146.63 27.95 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.335 1.454 . . . . 0.0 111.629 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.658 HG11 HG11 ' A' ' 33' ' ' VAL . 66.9 t -127.17 88.67 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 126.411 1.885 . . . . 0.0 106.039 162.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.37 -117.47 4.42 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -166.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -109.12 -9.78 15.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.854 1.262 . . . . 0.0 112.14 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.52 124.8 21.91 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -120.42 169.03 10.69 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.578 0.751 . . . . 0.0 112.569 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -145.2 156.42 43.85 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.637 1.575 . . . . 0.0 109.607 161.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -96.45 105.17 17.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.266 1.426 . . . . 0.0 108.982 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -110.79 104.45 13.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 122.157 0.98 . . . . 0.0 112.214 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.46 91.11 4.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.262 1.425 . . . . 0.0 109.324 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -69.79 143.8 52.86 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.33 1.452 . . . . 0.0 112.498 -173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -127.23 147.58 50.21 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 110.948 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.217 2.341 . . . . 0.0 109.674 -168.532 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.3 mm . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.9 p -40.74 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.27 2.628 . . . . 0.0 116.711 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -72.74 46.86 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.022 1.729 . . . . 0.0 111.728 165.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.69 120.23 17.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 128.009 2.718 . . . . 0.0 115.2 -168.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.43 -13.17 61.79 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.521 1.528 . . . . 0.0 113.499 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.8 p -112.5 -5.44 14.05 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.261 1.424 . . . . 0.0 114.359 -170.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -69.58 149.91 47.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.639 1.109 . . . . 0.0 111.396 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 t -67.88 163.44 21.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.886 0.374 . . . . 0.0 111.726 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.07 137.01 45.02 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.306 1.042 . . . . 0.0 110.871 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.0 m -65.75 150.88 47.8 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.379 0.672 . . . . 0.0 112.175 172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -55.29 116.61 2.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.608 1.563 . . . . 0.0 111.691 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -59.1 -16.35 18.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.57 -1.62 19.49 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -171.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -104.09 4.5 34.32 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -83.91 157.22 22.03 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.063 1.745 . . . . 0.0 114.671 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.4 p -143.19 149.0 37.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.118 2.167 . . . . 0.0 110.213 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -73.72 107.59 6.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.387 1.075 . . . . 0.0 110.928 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.7 ttmt -74.03 -33.27 63.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.207 1.403 . . . . 0.0 110.008 167.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -152.57 112.83 4.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.475 3.11 . . . . 0.0 108.199 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 156.69 36.06 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.244 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -54.09 129.72 35.85 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.909 2.406 . . . . 0.0 114.228 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -135.55 157.16 47.57 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.368 1.467 . . . . 0.0 110.316 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.93 136.4 41.03 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 156.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 p -73.82 -20.7 60.38 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.078 2.151 . . . . 0.0 114.065 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.01 -0.99 60.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.383 0.992 . . . . 0.0 112.995 -157.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -113.35 3.42 15.88 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.641 1.577 . . . . 0.0 113.1 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 64.13 7.83 3.68 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.982 1.313 . . . . 0.0 112.706 -165.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.6 p -88.73 168.66 12.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.303 1.841 . . . . 0.0 108.547 162.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 79' ' ' LEU . 8.0 t -121.04 114.43 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 125.552 1.541 . . . . 0.0 108.409 -169.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.1 m -103.44 148.21 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.581 0.752 . . . . 0.0 110.546 172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 ptp -154.13 169.82 22.64 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.441 1.096 . . . . 0.0 109.735 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -154.08 143.71 21.65 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 15.8 m -135.34 157.94 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.45 139.31 53.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.233 2.213 . . . . 0.0 108.585 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -138.44 121.73 17.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -153.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.84 2.04 55.45 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.01 -150.34 26.15 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.442 1.02 . . . . 0.0 112.548 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.78 160.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.286 2.234 . . . . 0.0 113.869 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -137.89 133.79 17.79 Favored Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 125.228 1.411 . . . . 0.0 108.31 155.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.56 167.3 80.45 Favored 'Cis proline' 0 CA--C 1.539 0.749 0 CA-C-N 120.127 1.081 . . . . 0.0 111.882 -5.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.89 160.03 37.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.768 0.827 . . . . 0.0 111.055 158.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -81.69 132.23 35.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.982 1.713 . . . . 0.0 109.799 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 45' ' ' VAL . 15.5 mt -75.55 116.24 53.12 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.985 0.914 . . . . 0.0 109.079 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.25 86.44 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.078 3.185 . . . . 0.0 110.148 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 43' ' ' ILE . 2.1 t -114.78 137.44 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 125.977 1.711 . . . . 0.0 110.953 -168.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -155.65 161.38 40.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.409 2.283 . . . . 0.0 108.696 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.44 124.14 37.72 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.871 1.268 . . . . 0.0 108.462 166.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.2 m -115.46 116.61 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.775 0.716 . . . . 0.0 110.251 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.88 141.84 57.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.658 0.783 . . . . 0.0 111.445 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -55.95 92.65 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.34 -16.63 3.38 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.701 1.62 . . . . 0.0 114.719 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 81.22 19.33 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.353 1.576 . . . . 0.0 111.818 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.84 -11.78 31.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.375 2.717 . . . . 0.0 113.681 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -24.24 60.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.966 2.906 . . . . 0.0 113.0 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.8 105.17 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.768 0.827 . . . . 0.0 110.737 -166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.1 131.51 46.36 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.936 0.398 . . . . 0.0 110.821 163.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -117.15 4.86 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 126.943 2.097 . . . . 0.0 112.547 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.77 95.42 0.89 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.212 1.405 . . . . 0.0 113.308 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 47.1 mtm -85.14 94.05 8.78 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.121 -0.987 . . . . 0.0 109.262 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.67 124.93 22.07 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.924 1.69 . . . . 0.0 112.21 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mm -94.73 -34.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.822 2.049 . . . . 0.0 110.609 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.61 163.69 25.26 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.957 0.903 . . . . 0.0 110.369 165.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -57.99 167.38 4.43 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.531 2.821 . . . . 0.0 116.347 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -33.22 102.4 0.21 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 128.915 2.886 . . . . 0.0 112.073 161.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.77 139.06 24.48 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.279 1.986 . . . . 0.0 112.666 -165.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.3 p -130.8 155.74 46.18 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.167 0.987 . . . . 0.0 112.017 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.98 128.96 55.71 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.999 1.72 . . . . 0.0 107.628 171.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -136.28 167.07 22.0 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 122.784 1.278 . . . . 0.0 112.939 -159.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.37 -8.65 59.37 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.254 1.821 . . . . 0.0 112.517 165.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.8 24.26 5.72 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.518 1.927 . . . . 0.0 112.28 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.67 -152.6 24.66 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.651 1.595 . . . . 0.0 111.986 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.89 174.86 21.5 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.44 1.578 . . . . 0.0 116.528 159.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.07 70.09 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 116.925 -2.042 . . . . 0.0 115.661 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -99.62 149.33 23.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.288 2.044 . . . . 0.0 113.887 -172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 45' ' ' VAL . 3.6 mt -149.26 145.59 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 126.213 1.805 . . . . 0.0 109.766 -170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -133.63 131.31 39.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.926 1.69 . . . . 0.0 109.04 159.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.5 ptp -140.91 166.79 23.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 111.11 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 79' ' ' LEU . 26.8 tt0 -129.27 151.51 49.85 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.197 169.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -144.72 161.25 44.22 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.597 1.559 . . . . 0.0 110.538 -159.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -58.95 127.77 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.521 3.481 . . . . 0.0 112.232 164.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.34 133.2 24.94 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.224 3.283 . . . . 0.0 113.334 166.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.28 -178.52 16.7 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.162 0.886 . . . . 0.0 113.049 -168.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.19 122.57 22.99 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.279 1.038 . . . . 0.0 111.393 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -126.44 117.18 22.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 107.862 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -77.77 100.67 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 mt -85.92 127.38 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.724 0.809 . . . . 0.0 108.862 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -112.85 151.11 30.8 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.929 1.291 . . . . 0.0 112.218 -174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG11 HG11 ' A' ' 33' ' ' VAL . 53.4 t -133.55 90.22 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 126.58 1.952 . . . . 0.0 106.461 169.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.6 -112.02 4.21 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -163.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -111.25 -9.16 14.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.456 1.102 . . . . 0.0 113.058 173.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.7 143.27 57.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 162.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -147.38 171.14 15.93 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -153.63 141.23 19.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.714 1.606 . . . . 0.0 111.34 166.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -74.8 112.38 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.845 0.858 . . . . 0.0 110.577 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -106.14 112.29 25.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.076 0.95 . . . . 0.0 110.861 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -82.12 86.5 6.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.87 1.668 . . . . 0.0 109.339 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -67.05 144.09 56.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.274 1.43 . . . . 0.0 111.937 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -123.17 158.96 29.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.073 1.749 . . . . 0.0 109.318 166.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.376 0 CA-C-O 116.791 -2.116 . . . . 0.0 110.581 -173.469 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.749 -0.643 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -59.22 119.63 7.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 111.224 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.29 53.35 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.297 1.039 . . . . 0.0 110.879 174.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.65 -166.64 12.27 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.213 1.387 . . . . 0.0 115.419 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp 68.02 -45.59 0.51 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 130.836 3.654 . . . . 0.0 114.318 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 p -91.43 -65.45 1.01 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.742 1.617 . . . . 0.0 112.752 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -56.12 159.9 3.16 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -167.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 p -93.95 160.51 14.69 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.15 1.38 . . . . 0.0 113.154 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.9 mmt -61.57 138.6 58.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.851 1.26 . . . . 0.0 113.795 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 m -73.8 157.75 35.84 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.402 1.081 . . . . 0.0 112.48 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.22 129.74 41.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.979 1.712 . . . . 0.0 111.371 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -58.85 -25.38 63.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.56 -20.09 14.6 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 47.4 mmtm -84.27 18.66 2.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 113.959 -169.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.51 156.61 17.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p -138.89 149.38 44.78 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.096 1.758 . . . . 0.0 110.762 167.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -71.02 110.45 5.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.76 1.224 . . . . 0.0 111.036 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 17.3 ttmt -81.37 -34.57 31.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.34 1.056 . . . . 0.0 110.475 170.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -151.34 111.68 4.15 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 128.529 2.732 . . . . 0.0 108.186 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 154.73 57.37 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 119.129 -0.462 . . . . 0.0 111.672 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -52.49 125.29 17.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.739 2.959 . . . . 0.0 114.247 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -140.07 168.07 20.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.366 1.066 . . . . 0.0 111.03 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.57 139.05 47.24 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.287 0.565 . . . . 0.0 110.019 170.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -66.29 -4.87 8.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.66 1.984 . . . . 0.0 114.483 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.29 9.65 86.32 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.836 1.207 . . . . 0.0 112.537 -164.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -135.68 17.72 3.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.967 1.707 . . . . 0.0 112.443 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 70.18 12.61 7.68 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.128 1.771 . . . . 0.0 113.517 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.3 p -112.49 152.22 29.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.367 1.467 . . . . 0.0 109.771 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 t -107.6 111.17 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.674 1.59 . . . . 0.0 109.132 -167.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 m -101.88 142.86 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.065 1.346 . . . . 0.0 110.516 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.451 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 1.3 ptp -153.19 171.37 18.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.113 0.965 . . . . 0.0 110.982 172.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -152.63 144.85 23.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.761 0.424 . . . . 0.0 111.48 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 88' ' ' VAL . 17.1 m -137.87 162.16 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.21 152.34 48.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.301 2.24 . . . . 0.0 109.571 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 74.2 t80 -147.85 121.66 9.3 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -157.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -79.04 -6.38 56.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.576 1.95 . . . . 0.0 115.249 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.28 -147.43 19.69 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.442 1.019 . . . . 0.0 113.598 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.52 160.38 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.441 2.297 . . . . 0.0 114.509 175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -139.76 124.33 11.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.998 1.719 . . . . 0.0 108.069 164.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.71 172.55 62.51 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 CA-C-N 119.988 1.031 . . . . 0.0 111.328 -7.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 23.7 p -152.62 165.48 35.09 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.937 -0.477 . . . . 0.0 111.683 158.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.53 125.34 43.73 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.161 2.184 . . . . 0.0 110.048 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.1 mt -76.34 122.2 86.31 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.35 -166.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.17 70.7 3.75 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 125.104 3.869 . . . . 0.0 110.311 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.739 HG21 HD13 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -97.52 140.06 18.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.374 1.47 . . . . 0.0 111.287 -174.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -155.69 162.08 40.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.245 1.818 . . . . 0.0 108.9 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.33 129.9 45.41 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.951 0.9 . . . . 0.0 108.597 165.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.94 121.06 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 118.453 0.569 . . . . 0.0 110.662 -170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.0 141.05 58.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.548 0.739 . . . . 0.0 111.878 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -52.15 105.47 0.11 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.274 1.43 . . . . 0.0 112.598 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 -12.95 21.86 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.287 1.423 . . . . 0.0 114.644 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 73.68 71.77 Favored Pre-proline 0 CA--C 1.545 0.75 0 CA-C-N 119.066 1.433 . . . . 0.0 110.596 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.34 -9.01 24.63 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.831 3.021 . . . . 0.0 114.024 -172.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.4 -28.31 46.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.802 2.441 . . . . 0.0 112.684 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 t -100.09 108.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.992 0.917 . . . . 0.0 110.087 -168.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -65.93 128.27 35.37 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.971 0.415 . . . . 0.0 110.744 164.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -115.36 4.53 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.585 1.954 . . . . 0.0 112.423 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.74 107.59 3.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.969 1.308 . . . . 0.0 113.977 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.7 mtm -86.4 88.02 7.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.147 0.979 . . . . 0.0 109.495 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.49 122.19 12.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.997 1.319 . . . . 0.0 112.054 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mm -95.3 -30.22 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.149 1.779 . . . . 0.0 110.804 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.43 166.73 14.72 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.764 0.826 . . . . 0.0 109.548 164.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.68 166.56 6.34 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.573 2.182 . . . . 0.0 114.645 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -35.79 97.9 0.14 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 128.982 2.913 . . . . 0.0 111.457 159.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.64 151.12 32.07 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.828 1.685 . . . . 0.0 114.166 -159.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 p -131.6 150.74 52.04 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.718 1.607 . . . . 0.0 112.085 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.51 125.5 52.01 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.194 1.398 . . . . 0.0 108.203 172.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -138.24 176.76 8.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.68 1.592 . . . . 0.0 110.088 -161.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -93.12 -47.21 7.07 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.053 1.341 . . . . 0.0 110.354 169.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.8 27.45 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.118 2.567 . . . . 0.0 115.161 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.46 -149.61 18.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.362 1.458 . . . . 0.0 111.778 -169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.53 173.35 29.59 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 122.941 1.301 . . . . 0.0 115.004 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.52 -7.96 66.17 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 116.9 -2.056 . . . . 0.0 115.689 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -88.11 146.27 25.51 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.264 2.032 . . . . 0.0 113.609 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.739 HD13 HG21 ' A' ' 45' ' ' VAL . 5.8 mt -147.91 141.84 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.656 1.582 . . . . 0.0 109.337 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -136.95 137.34 39.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.548 1.139 . . . . 0.0 109.9 163.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -147.07 161.8 40.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.14 1.776 . . . . 0.0 110.916 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.635 ' C ' HD12 ' A' ' 79' ' ' LEU . 39.3 tt0 -120.88 150.55 40.89 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.172 -0.955 . . . . 0.0 110.706 168.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.5 mp -140.16 161.32 56.14 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.413 1.485 . . . . 0.0 110.216 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.95 126.53 11.97 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.698 2.932 . . . . 0.0 110.939 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.07 142.27 54.86 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.781 2.987 . . . . 0.0 113.927 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 123.63 -153.51 17.28 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -160.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -109.16 130.91 55.48 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 117.978 0.889 . . . . 0.0 111.203 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.47 124.17 23.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.381 1.472 . . . . 0.0 109.395 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.39 109.37 18.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 mt -90.6 123.52 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 123.889 0.876 . . . . 0.0 108.929 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -110.57 143.78 40.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.308 1.443 . . . . 0.0 111.572 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 33' ' ' VAL . 62.8 t -121.85 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 162.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -100.73 1.67 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.096 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -122.69 -16.28 7.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.178 1.391 . . . . 0.0 113.5 168.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -57.23 133.52 55.14 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.72 169.01 18.56 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -171.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -151.97 128.75 10.89 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.006 1.722 . . . . 0.0 109.476 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.19 117.97 14.49 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 110.253 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -118.48 112.15 19.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.406 1.082 . . . . 0.0 111.549 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -75.89 105.55 7.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 109.705 168.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -86.94 141.18 28.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.712 1.605 . . . . 0.0 112.398 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -123.88 141.52 51.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.815 2.446 . . . . 0.0 107.641 167.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 115.508 -2.829 . . . . 0.0 109.349 -178.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -58.25 140.12 53.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.74 0.781 . . . . 0.0 112.116 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -80.85 59.25 3.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.906 1.683 . . . . 0.0 110.69 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.87 97.68 0.01 OUTLIER Glycine 0 CA--C 1.53 1.001 0 C-N-CA 130.697 3.998 . . . . 0.0 116.978 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.22 -22.14 62.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.402 1.481 . . . . 0.0 113.444 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -101.98 -11.53 18.87 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.658 1.583 . . . . 0.0 114.54 -170.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -71.39 152.36 43.22 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.799 1.181 . . . . 0.0 112.252 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 p -65.5 156.8 31.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.493 1.117 . . . . 0.0 111.551 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.8 mmm -66.1 130.36 42.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.351 0.66 . . . . 0.0 109.984 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 61.7 m -61.44 148.77 40.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.069 0.548 . . . . 0.0 111.177 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -54.96 118.77 4.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.071 1.349 . . . . 0.0 112.114 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -55.55 -17.38 5.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.55 8.98 19.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.008 1.723 . . . . 0.0 114.758 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -119.78 3.08 11.12 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -81.64 159.43 24.01 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.1 p -140.93 141.05 34.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.645 1.978 . . . . 0.0 109.823 168.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.51 110.68 7.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 18.9 ttmt -79.09 -37.05 39.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.569 1.148 . . . . 0.0 110.489 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.2 104.09 4.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 128.402 2.681 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.83 149.14 81.38 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.785 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.22 123.87 8.29 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.683 3.589 . . . . 0.0 116.02 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 t -139.95 157.21 46.04 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.825 1.65 . . . . 0.0 111.244 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 12.6 t0 -58.84 146.04 38.72 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.987 0.915 . . . . 0.0 110.363 162.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.8 p -84.0 -3.21 57.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 129.673 3.189 . . . . 0.0 114.025 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 79.95 4.1 89.51 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.383 1.468 . . . . 0.0 112.809 -167.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -127.98 19.61 6.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.054 1.742 . . . . 0.0 111.498 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 64.95 19.39 11.84 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.543 1.937 . . . . 0.0 113.526 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -114.55 153.25 30.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.979 1.711 . . . . 0.0 109.264 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.75 110.76 33.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 108.918 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -95.99 148.37 5.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.685 1.194 . . . . 0.0 110.23 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.465 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.5 ptp -152.06 164.75 36.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.983 0.913 . . . . 0.0 110.075 168.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -151.25 145.05 25.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 -172.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 25.6 m -139.55 161.21 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.7 132.1 51.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.153 1.781 . . . . 0.0 108.369 168.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 40.9 t80 -125.14 117.81 24.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.083 0.953 . . . . 0.0 112.832 -159.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.96 -3.69 57.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.196 1.398 . . . . 0.0 114.574 -171.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.9 -149.42 25.32 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.52 1.057 . . . . 0.0 113.145 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -49.89 160.43 0.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.571 1.948 . . . . 0.0 114.265 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -137.35 135.91 19.99 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.813 1.645 . . . . 0.0 107.065 156.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.84 167.79 79.22 Favored 'Cis proline' 0 CA--C 1.538 0.681 0 CA-C-N 120.225 1.116 . . . . 0.0 111.637 -7.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.07 162.37 34.09 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.589 0.755 . . . . 0.0 111.534 159.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -85.32 129.37 34.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.015 2.126 . . . . 0.0 109.71 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -70.68 120.89 81.73 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.176 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.33 67.89 2.69 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 125.04 3.827 . . . . 0.0 110.625 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.38 151.31 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.701 1.2 . . . . 0.0 110.62 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -168.56 166.42 12.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.004 2.121 . . . . 0.0 108.554 167.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.52 132.44 46.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.602 1.161 . . . . 0.0 108.845 168.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.18 115.12 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.014 0.824 . . . . 0.0 109.947 -171.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.81 150.93 43.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.498 0.666 . . . . 0.0 112.393 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -51.01 95.29 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.666 1.986 . . . . 0.0 112.952 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.23 -13.59 7.04 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.406 1.479 . . . . 0.0 115.28 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.19 83.42 22.21 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 119.78 1.79 . . . . 0.0 112.26 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.23 -10.72 29.81 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.464 2.776 . . . . 0.0 114.313 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.77 -16.62 55.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.01 2.524 . . . . 0.0 113.9 -176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.04 114.2 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.029 0.932 . . . . 0.0 111.061 -165.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -68.46 128.03 35.14 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 111.442 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -108.19 -1.16 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.89 2.076 . . . . 0.0 112.53 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 126.04 28.51 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.244 1.018 . . . . 0.0 112.799 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.9 mtm -107.41 98.48 8.09 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.946 1.298 . . . . 0.0 107.877 168.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.97 132.4 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.509 0.723 . . . . 0.0 112.475 -172.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.7 -42.19 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.782 1.633 . . . . 0.0 109.944 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.99 160.64 54.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.09 167.26 5.95 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.708 2.272 . . . . 0.0 115.098 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -34.58 101.25 0.2 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 129.356 3.063 . . . . 0.0 112.641 168.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.64 143.32 33.84 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.842 1.695 . . . . 0.0 112.964 -165.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -135.25 162.27 33.04 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.466 1.506 . . . . 0.0 111.198 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 110.92 12.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.648 1.579 . . . . 0.0 107.589 173.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.14 170.03 8.67 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.958 0.885 . . . . 0.0 111.313 -170.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -84.15 -2.74 57.35 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.753 0.821 . . . . 0.0 112.339 163.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.62 22.73 4.31 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.098 2.159 . . . . 0.0 112.203 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.19 -166.47 28.99 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.406 1.479 . . . . 0.0 112.696 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.23 -176.12 30.11 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 122.139 0.855 . . . . 0.0 114.866 170.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.71 0.29 72.55 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.211 -1.883 . . . . 0.0 115.85 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -117.21 149.07 41.01 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.944 1.872 . . . . 0.0 112.542 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 9.9 mt -149.43 143.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.225 1.81 . . . . 0.0 109.688 -168.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -141.5 135.45 30.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 110.903 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.458 ' SD ' HD11 ' A' ' 79' ' ' LEU . 16.7 ptp -143.59 166.84 23.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.214 1.805 . . . . 0.0 111.701 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.584 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -126.2 151.14 47.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.599 1.16 . . . . 0.0 110.4 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.2 mp -143.86 160.65 49.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.359 1.464 . . . . 0.0 111.264 -160.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.85 125.48 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.956 3.104 . . . . 0.0 111.515 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -49.06 127.81 18.1 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.34 3.36 . . . . 0.0 112.926 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.04 25.73 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -161.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -101.25 125.22 47.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.392 0.677 . . . . 0.0 110.7 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -132.78 119.59 20.49 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.011 1.324 . . . . 0.0 109.997 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.97 109.95 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 mt -94.75 131.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.636 0.731 . . . . 0.0 109.256 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.57 147.1 37.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.484 1.914 . . . . 0.0 111.595 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.4 92.06 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.137 1.775 . . . . 0.0 106.616 154.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.89 -122.85 6.56 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 121.46 -0.775 . . . . 0.0 111.998 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -101.3 -8.48 22.07 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 156.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.06 127.47 31.77 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 166.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.93 169.69 17.35 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.535 0.734 . . . . 0.0 112.938 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -157.84 124.52 4.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.201 1.8 . . . . 0.0 110.534 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -73.37 116.57 14.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 111.064 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -117.69 113.73 22.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.016 1.326 . . . . 0.0 111.863 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -75.23 98.35 3.74 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.44 1.496 . . . . 0.0 109.976 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -76.54 127.43 32.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.842 1.257 . . . . 0.0 112.27 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -106.84 133.2 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.172 2.189 . . . . 0.0 107.796 163.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.34 0 CA-C-O 115.649 -2.751 . . . . 0.0 109.737 175.396 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p -136.16 -172.79 3.22 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.754 0.822 . . . . 0.0 111.418 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -133.86 88.35 2.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.338 1.455 . . . . 0.0 109.567 167.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -66.17 83.9 0.1 OUTLIER Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.327 0.965 . . . . 0.0 115.005 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.47 -15.89 3.19 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.887 1.675 . . . . 0.0 113.709 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -105.56 -15.48 14.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.44 2.696 . . . . 0.0 114.992 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.54 ' CE2' ' HA3' ' A' ' 4' ' ' GLY . 9.3 m-30 -71.45 155.39 40.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.526 1.512 . . . . 0.0 112.738 -171.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.0 p -79.82 165.72 22.45 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.335 1.054 . . . . 0.0 112.021 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.2 mmt -69.08 138.8 54.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.091 0.956 . . . . 0.0 112.926 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 55.4 m -65.08 159.97 22.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.752 0.821 . . . . 0.0 111.86 170.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -61.17 115.13 3.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 110.934 170.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -58.79 -9.52 1.83 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.3 -4.29 9.43 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -98.7 13.1 33.39 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.358 1.435 . . . . 0.0 113.623 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -88.61 160.15 17.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.365 1.466 . . . . 0.0 113.879 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.9 p -140.14 139.5 35.79 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.463 1.905 . . . . 0.0 109.783 169.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -70.05 100.83 1.69 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.545 1.138 . . . . 0.0 111.059 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.8 ttmt -71.26 -35.66 71.48 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.798 1.239 . . . . 0.0 110.321 169.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -146.54 107.26 4.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.68 2.392 . . . . 0.0 107.971 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.52 150.77 85.09 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.29 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.41 116.9 2.0 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 125.11 3.873 . . . . 0.0 115.196 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -138.17 161.59 36.42 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.812 2.045 . . . . 0.0 110.445 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.59 149.1 40.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.049 0.452 . . . . 0.0 110.327 166.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.9 p -78.8 -5.16 52.67 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.773 2.029 . . . . 0.0 114.242 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.93 3.37 90.51 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.287 0.946 . . . . 0.0 112.792 -163.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.67 16.03 4.37 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.092 1.757 . . . . 0.0 112.466 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 70.62 6.99 6.05 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.587 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.3 p -98.79 167.62 10.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.458 1.903 . . . . 0.0 109.14 164.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG21 HD13 ' A' ' 79' ' ' LEU . 11.5 t -124.56 116.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 125.723 1.609 . . . . 0.0 109.232 -166.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.09 146.95 13.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.032 1.333 . . . . 0.0 109.94 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.467 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 2.4 ptp -152.76 166.06 33.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.575 0.75 . . . . 0.0 110.117 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -151.6 145.56 25.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.355 -175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 88' ' ' VAL . 17.3 m -137.6 159.62 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.95 141.2 52.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.13 1.772 . . . . 0.0 108.855 166.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 46.6 t80 -137.3 114.92 11.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.73 0.812 . . . . 0.0 112.565 -156.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -80.79 -2.87 48.88 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.78 -148.08 16.45 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.216 0.917 . . . . 0.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -51.13 163.32 0.23 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.575 1.95 . . . . 0.0 114.532 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -139.52 132.23 15.29 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 156.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -77.08 170.84 70.56 Favored 'Cis proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.368 1.167 . . . . 0.0 111.459 -6.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -159.59 161.22 35.08 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.913 0.863 . . . . 0.0 112.215 157.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -83.7 128.47 34.56 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.749 2.02 . . . . 0.0 109.275 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG23 HG13 ' A' ' 88' ' ' VAL . 56.2 mt -70.1 119.04 69.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.0 72.56 3.27 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.853 3.702 . . . . 0.0 109.425 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -95.81 144.16 10.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.768 1.627 . . . . 0.0 110.687 -169.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -166.75 155.4 10.36 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.756 1.622 . . . . 0.0 108.865 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 79' ' ' LEU . . . -122.46 118.02 27.35 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.291 1.037 . . . . 0.0 108.422 168.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.53 118.1 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 118.207 0.458 . . . . 0.0 110.196 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.16 142.64 54.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.092 0.472 . . . . 0.0 111.243 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -48.72 100.65 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.876 1.671 . . . . 0.0 113.227 -174.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.65 -11.89 10.23 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.384 1.469 . . . . 0.0 115.287 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.01 76.79 76.36 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 119.71 1.755 . . . . 0.0 112.34 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.07 -12.7 36.55 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.561 2.841 . . . . 0.0 114.854 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.03 -16.02 54.49 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.644 2.778 . . . . 0.0 113.445 175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.77 105.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.431 1.092 . . . . 0.0 111.169 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -75.04 124.27 26.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.835 0.35 . . . . 0.0 111.656 170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.25 4.0 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.609 1.964 . . . . 0.0 112.908 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.96 118.91 9.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.154 0.888 . . . . 0.0 112.42 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.2 mtt -103.1 95.88 6.42 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 126.84 29.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.11 1.364 . . . . 0.0 111.151 -168.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mm -91.13 -32.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.825 1.25 . . . . 0.0 110.752 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.7 OUTLIER -105.11 159.55 28.99 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.352 1.061 . . . . 0.0 109.471 168.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -57.29 162.35 9.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.588 2.192 . . . . 0.0 114.84 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -32.23 106.13 0.25 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 128.483 2.713 . . . . 0.0 112.353 169.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.19 143.96 29.1 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.11 1.874 . . . . 0.0 112.949 -168.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -134.28 152.82 52.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.864 1.666 . . . . 0.0 110.272 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.47 112.16 23.69 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 165.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -116.53 168.1 10.47 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 0.0 109.94 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -77.84 -10.99 59.84 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.032 -1.043 . . . . 0.0 113.026 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -128.13 12.14 6.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.254 1.822 . . . . 0.0 112.753 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.55 -169.67 35.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.235 1.874 . . . . 0.0 111.488 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 110.66 -175.78 18.3 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.295 0.942 . . . . 0.0 114.91 170.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -6.33 78.39 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 116.843 -2.087 . . . . 0.0 115.679 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.27 150.46 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.425 2.112 . . . . 0.0 113.274 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 45' ' ' VAL . 4.3 mt -150.12 144.85 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.536 1.934 . . . . 0.0 110.176 -166.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.501 ' H ' HG22 ' A' ' 62' ' ' THR . 75.2 tt0 -140.91 135.95 31.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.239 1.016 . . . . 0.0 111.326 162.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.7 ptp -145.92 161.89 39.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.761 2.024 . . . . 0.0 111.229 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.6 tt0 -120.5 156.63 31.12 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.044 -1.035 . . . . 0.0 110.735 169.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 29' ' ' VAL . 5.0 mp -144.39 159.72 50.85 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.71 1.204 . . . . 0.0 112.733 -162.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.86 123.75 13.59 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.861 3.707 . . . . 0.0 112.095 165.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 140.63 71.04 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.756 2.97 . . . . 0.0 112.825 170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.82 -154.84 16.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -161.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -109.26 125.23 52.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.825 0.812 . . . . 0.0 112.251 -171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -135.02 134.32 40.32 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.072 0.949 . . . . 0.0 109.769 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.35 110.57 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.5 mt -98.39 113.69 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.554 0.742 . . . . 0.0 109.321 -168.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -98.2 138.98 34.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.373 1.869 . . . . 0.0 111.527 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG11 HG11 ' A' ' 33' ' ' VAL . 24.5 t -118.75 84.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 155.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.83 -117.84 5.34 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.949 0.785 . . . . 0.0 112.26 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -112.15 -10.99 13.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 111.833 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.65 124.44 20.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.754 1.221 . . . . 0.0 108.448 159.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.73 175.87 8.48 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.968 0.907 . . . . 0.0 113.248 -173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -155.15 133.29 11.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.38 1.872 . . . . 0.0 108.873 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -74.45 111.57 9.77 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.98 0.512 . . . . 0.0 109.681 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -109.09 104.27 13.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.285 1.034 . . . . 0.0 110.88 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 100.29 2.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.903 163.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -73.9 135.62 43.32 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.557 1.943 . . . . 0.0 111.515 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -114.45 153.25 30.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.073 1.349 . . . . 0.0 110.105 163.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 116.915 -2.047 . . . . 0.0 109.628 -171.131 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.0 mm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -39.27 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.504 2.722 . . . . 0.0 117.304 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -78.28 56.87 1.77 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.423 -1.423 . . . . 0.0 110.465 164.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.27 118.2 13.92 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.636 2.065 . . . . 0.0 115.177 -166.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.55 -11.53 7.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.903 1.281 . . . . 0.0 113.777 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.0 p -107.05 -26.28 11.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.718 1.607 . . . . 0.0 114.795 -170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -67.46 142.63 56.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.093 1.315 . . . . 0.0 110.707 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -85.21 174.76 9.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.43 -0.794 . . . . 0.0 112.425 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -69.54 141.23 53.88 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.621 1.568 . . . . 0.0 113.021 -167.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 m -68.15 155.34 39.83 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.192 0.997 . . . . 0.0 112.037 169.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -59.93 118.15 5.9 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.053 1.341 . . . . 0.0 111.483 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -56.91 -14.0 3.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.49 -5.46 12.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.94 6.52 48.68 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 120.286 1.403 . . . . 0.0 113.952 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -82.48 162.76 21.95 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -146.52 137.65 24.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.566 2.346 . . . . 0.0 110.326 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -69.03 109.85 4.18 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.763 1.225 . . . . 0.0 111.731 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 3.4 mtmt -72.43 -44.47 62.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.543 1.137 . . . . 0.0 109.6 166.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -144.48 106.65 4.35 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 128.171 2.588 . . . . 0.0 107.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.66 153.49 51.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 119.271 -0.395 . . . . 0.0 110.46 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -53.22 129.97 36.05 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.67 2.914 . . . . 0.0 114.672 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -138.44 160.4 39.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.596 1.558 . . . . 0.0 110.131 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 151.3 47.03 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.615 -0.678 . . . . 0.0 109.993 167.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.7 p -84.37 -21.31 30.92 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.368 2.267 . . . . 0.0 114.729 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.21 -10.93 73.35 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.464 1.507 . . . . 0.0 113.608 -160.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.48 5.66 48.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.479 1.512 . . . . 0.0 112.821 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 60.44 35.05 20.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.659 1.584 . . . . 0.0 112.315 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -128.98 167.04 18.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.429 2.292 . . . . 0.0 108.548 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' CG2' HD13 ' A' ' 79' ' ' LEU . 14.1 t -117.93 122.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 126.376 1.871 . . . . 0.0 109.043 -170.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.26 148.28 13.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 125.178 1.391 . . . . 0.0 110.321 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 4.3 ptp -154.32 170.7 20.67 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.514 0.726 . . . . 0.0 109.565 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.66 141.58 20.2 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 88' ' ' VAL . 18.7 m -135.37 160.24 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.89 148.95 44.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.617 2.367 . . . . 0.0 108.794 168.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 51.0 t80 -141.19 123.54 15.77 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -162.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.55 -7.29 59.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.1 1.36 . . . . 0.0 114.561 -171.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.12 -135.2 8.26 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.083 0.849 . . . . 0.0 113.404 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 158.29 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.236 2.615 . . . . 0.0 115.564 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -142.84 124.43 8.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.143 2.177 . . . . 0.0 106.605 165.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -75.36 171.27 68.94 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 CA-C-N 120.866 1.345 . . . . 0.0 110.343 -9.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.8 p -156.32 158.29 37.18 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.4 0.619 . . . . 0.0 111.255 157.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -81.02 128.75 34.06 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.687 1.595 . . . . 0.0 109.287 171.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 45' ' ' VAL . 63.2 mt -73.07 118.0 64.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.84 77.59 3.03 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 124.772 3.648 . . . . 0.0 109.138 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.2 t -112.84 135.28 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.96 1.304 . . . . 0.0 111.196 -164.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.12 155.86 33.27 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.128 1.771 . . . . 0.0 109.022 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 125.03 45.76 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.351 1.061 . . . . 0.0 108.209 167.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.57 117.17 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.47 144.11 57.42 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.959 -0.463 . . . . 0.0 111.66 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -53.77 104.79 0.11 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.239 1.015 . . . . 0.0 112.749 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.96 -16.62 9.37 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.667 1.604 . . . . 0.0 114.394 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.94 75.13 67.53 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.033 1.417 . . . . 0.0 112.026 -174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.75 -11.15 30.26 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.193 2.595 . . . . 0.0 114.509 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -16.55 57.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.091 2.556 . . . . 0.0 112.88 178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.11 104.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 110.211 -164.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -68.93 118.99 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.028 0.442 . . . . 0.0 110.99 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.95 0.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.53 1.932 . . . . 0.0 112.507 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.58 126.95 30.97 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.6 mtp -100.6 96.61 7.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.938 0.895 . . . . 0.0 109.539 163.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.53 126.43 26.53 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.813 0.733 . . . . 0.0 111.832 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -99.73 -34.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.409 1.884 . . . . 0.0 110.359 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -91.06 166.55 18.36 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.661 0.784 . . . . 0.0 109.723 163.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.73 169.6 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 115.033 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.41 102.17 0.27 Allowed Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 129.094 2.958 . . . . 0.0 112.045 168.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.8 147.73 21.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.497 2.131 . . . . 0.0 113.399 -162.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -133.37 148.07 51.83 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.759 1.223 . . . . 0.0 111.697 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.85 125.42 50.87 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.97 176.85 7.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.369 1.468 . . . . 0.0 110.499 -165.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -93.52 -29.92 15.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.892 1.277 . . . . 0.0 111.862 165.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -100.7 36.87 1.82 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.051 2.14 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.6 -149.59 19.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.256 1.408 . . . . 0.0 111.994 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.18 176.12 31.71 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 123.19 1.439 . . . . 0.0 115.598 165.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.39 -17.41 55.51 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.355 -1.803 . . . . 0.0 115.554 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -97.27 149.66 21.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.782 1.791 . . . . 0.0 114.841 -167.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.455 ' CD1' HG21 ' A' ' 45' ' ' VAL . 5.9 mt -150.42 142.99 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.642 1.977 . . . . 0.0 110.225 -165.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 62' ' ' THR . 46.2 tt0 -137.36 135.06 36.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.345 1.458 . . . . 0.0 109.961 161.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.6 ptp -144.41 161.76 38.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.689 1.996 . . . . 0.0 111.316 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.657 ' C ' HD12 ' A' ' 79' ' ' LEU . 42.5 tt0 -120.05 149.61 41.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.908 1.283 . . . . 0.0 110.686 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.657 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.7 mp -146.18 157.54 49.46 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.976 1.31 . . . . 0.0 111.02 -162.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.16 123.55 13.9 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.916 3.744 . . . . 0.0 113.36 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.12 125.99 16.13 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.591 3.527 . . . . 0.0 113.194 169.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.07 -170.83 20.06 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.405 1.002 . . . . 0.0 111.805 -163.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -87.23 121.44 29.68 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 112.184 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -127.4 125.97 41.59 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.658 1.583 . . . . 0.0 108.625 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.12 113.07 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.61 117.91 44.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -100.67 147.39 26.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.422 1.089 . . . . 0.0 111.728 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG21 HG11 ' A' ' 33' ' ' VAL . 74.6 t -120.49 90.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 157.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.45 -110.19 3.01 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 119.163 -0.798 . . . . 0.0 111.218 -170.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -115.22 -11.63 11.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.285 1.034 . . . . 0.0 112.748 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.3 tp -63.81 135.57 56.72 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.067 . . . . 0.0 108.227 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -139.76 174.19 10.77 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -152.9 151.38 30.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.896 1.278 . . . . 0.0 110.615 159.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -80.97 119.96 24.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.021 1.328 . . . . 0.0 110.017 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -116.79 113.35 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.752 0.787 . . . . 0.0 112.286 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -83.91 95.03 8.37 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.66 1.584 . . . . 0.0 109.933 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -75.82 141.42 42.49 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.492 1.517 . . . . 0.0 113.229 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -118.86 155.23 31.59 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.26 1.424 . . . . 0.0 111.189 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.978 2.227 . . . . 0.0 109.811 -170.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.9 p -68.44 93.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.892 1.677 . . . . 0.0 113.318 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -72.22 48.7 0.18 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.118 1.767 . . . . 0.0 111.759 172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.9 103.35 0.16 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 128.321 2.867 . . . . 0.0 116.482 -168.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -58.61 -13.34 5.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.675 1.59 . . . . 0.0 114.06 170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.4 p -101.54 -9.94 20.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.136 1.775 . . . . 0.0 113.929 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -73.41 144.93 46.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.87 1.214 . . . . 0.0 111.52 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.6 p -72.63 161.97 30.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.658 0.742 . . . . 0.0 111.654 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.4 mmm -68.01 137.47 55.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 111.027 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 59.6 m -63.51 158.37 21.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.374 0.607 . . . . 0.0 111.44 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -57.53 130.24 45.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.175 1.39 . . . . 0.0 110.858 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -69.44 -8.89 50.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.35 -23.53 4.12 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.101 1.361 . . . . 0.0 114.386 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 0.5 5.11 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -82.35 161.84 22.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.766 1.627 . . . . 0.0 115.172 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.3 p -142.06 138.82 32.02 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.935 2.094 . . . . 0.0 110.052 172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -70.63 108.35 4.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.065 0.946 . . . . 0.0 110.29 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 1.6 ttmt -81.41 -36.3 29.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.683 0.793 . . . . 0.0 110.494 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -143.83 102.02 3.84 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 128.005 2.522 . . . . 0.0 107.56 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.24 152.6 62.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.108 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.75 122.27 7.81 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.312 3.341 . . . . 0.0 114.895 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.4 t -132.31 157.08 45.36 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.777 1.631 . . . . 0.0 109.519 171.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -61.16 149.5 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 160.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.6 p -91.95 -16.99 25.8 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.922 2.089 . . . . 0.0 114.757 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -7.69 79.57 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.927 -161.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -92.82 5.9 49.59 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.262 1.531 . . . . 0.0 112.342 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 59.95 24.13 13.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.973 1.709 . . . . 0.0 113.049 -161.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.2 p -111.73 170.03 8.42 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.733 2.013 . . . . 0.0 109.172 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -115.32 122.71 69.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 126.288 1.835 . . . . 0.0 108.718 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.08 147.35 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 110.337 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.1 ptp -152.91 164.28 38.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.074 0.95 . . . . 0.0 110.344 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -151.51 147.48 26.88 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.645 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.0 m -136.32 168.43 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.98 148.94 52.27 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.355 1.862 . . . . 0.0 109.071 162.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -136.01 121.76 19.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.171 0.988 . . . . 0.0 112.415 -159.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -77.61 -6.1 52.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.981 1.312 . . . . 0.0 114.473 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.14 -156.66 32.91 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.598 1.094 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.05 170.66 0.12 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.835 2.054 . . . . 0.0 114.143 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 67' ' ' MET . 41.2 mmtm -143.5 138.0 15.04 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.573 1.949 . . . . 0.0 107.847 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -77.16 169.16 74.96 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 120.327 1.152 . . . . 0.0 111.609 -9.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.5 p -158.0 160.29 37.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.84 0.856 . . . . 0.0 110.834 160.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -81.23 125.81 30.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.669 1.588 . . . . 0.0 109.94 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 45' ' ' VAL . 19.1 mt -70.96 118.64 67.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.97 74.26 2.39 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.957 3.771 . . . . 0.0 111.321 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 43' ' ' ILE . 2.4 t -105.85 140.47 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 125.461 1.504 . . . . 0.0 111.826 -168.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -157.98 162.49 38.2 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.368 1.867 . . . . 0.0 109.771 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.12 120.76 29.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.624 1.57 . . . . 0.0 107.837 168.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 m -116.31 114.44 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.886 0.766 . . . . 0.0 110.481 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.84 157.03 37.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.453 1.101 . . . . 0.0 112.9 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -41.63 103.3 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.476 1.911 . . . . 0.0 114.391 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.07 -3.71 64.7 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.611 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.17 72.53 71.29 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.589 1.695 . . . . 0.0 111.337 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.09 -12.78 36.23 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.817 3.012 . . . . 0.0 114.425 -170.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.06 -24.75 30.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 112.686 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.65 101.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.723 0.809 . . . . 0.0 110.781 -161.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -65.94 123.84 20.91 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.988 0.423 . . . . 0.0 111.936 169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.45 7.92 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.707 2.003 . . . . 0.0 112.732 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.26 103.77 1.32 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.951 1.3 . . . . 0.0 113.835 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtm -85.84 89.19 7.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.72 127.66 32.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.31 1.044 . . . . 0.0 111.804 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.72 -26.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.601 1.56 . . . . 0.0 110.978 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -101.56 155.63 36.15 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.016 0.927 . . . . 0.0 109.875 165.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.53 163.76 12.36 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.791 2.328 . . . . 0.0 114.9 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -23.87 96.84 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 129.67 3.188 . . . . 0.0 113.148 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.98 133.95 22.54 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.237 1.958 . . . . 0.0 111.635 -166.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.4 p -127.33 150.71 49.47 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 110.402 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.5 129.74 50.74 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 169.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -138.71 167.66 21.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.329 1.062 . . . . 0.0 112.152 -166.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -85.3 -12.88 51.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.935 2.094 . . . . 0.0 113.076 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -122.58 24.59 9.14 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.702 2.001 . . . . 0.0 111.429 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.16 -140.78 12.0 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.24 1.876 . . . . 0.0 111.11 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.14 -173.41 55.16 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 121.955 0.753 . . . . 0.0 113.892 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.2 -2.4 87.08 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 117.845 -1.53 . . . . 0.0 115.971 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.7 t80 -112.4 146.84 37.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.954 1.702 . . . . 0.0 111.994 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 45' ' ' VAL . 12.4 mt -145.67 141.84 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.932 1.293 . . . . 0.0 110.005 -169.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 62' ' ' THR . 57.4 tt0 -132.35 133.57 44.14 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.12 1.368 . . . . 0.0 110.202 162.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.9 ptp -144.98 166.52 25.06 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.164 1.786 . . . . 0.0 111.191 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.582 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.4 tt0 -125.66 148.56 48.96 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.394 1.078 . . . . 0.0 110.451 172.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.7 mp -138.87 160.61 62.25 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.34 1.456 . . . . 0.0 110.312 -165.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.13 128.7 18.01 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 123.592 2.861 . . . . 0.0 111.187 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.71 136.01 16.69 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.57 3.514 . . . . 0.0 114.136 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.81 -171.5 13.98 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.357 0.98 . . . . 0.0 114.147 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -67.35 116.7 8.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.418 1.487 . . . . 0.0 112.507 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -132.65 120.38 21.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.65 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.83 108.9 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 61.0 mt -91.22 142.47 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -129.01 147.28 50.86 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.793 1.237 . . . . 0.0 112.775 -170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.52 92.42 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.332 1.853 . . . . 0.0 106.684 159.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.34 -109.88 2.96 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.54 -15.23 13.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.138 1.375 . . . . 0.0 112.431 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.37 132.2 52.73 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 164.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.15 169.12 18.31 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.344 0.658 . . . . 0.0 112.671 -168.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -156.45 128.06 7.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.24 1.816 . . . . 0.0 109.567 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -74.7 121.41 21.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.087 0.555 . . . . 0.0 110.785 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -120.75 130.48 54.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.564 1.146 . . . . 0.0 111.422 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -101.2 90.73 4.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.699 1.199 . . . . 0.0 109.071 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -68.23 141.45 55.93 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.314 1.446 . . . . 0.0 112.574 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -110.33 167.51 10.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.277 1.431 . . . . 0.0 111.205 165.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 116.702 -2.165 . . . . 0.0 109.956 -172.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.3 p -68.52 102.62 1.49 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.315 2.246 . . . . 0.0 113.471 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -75.11 29.57 0.09 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.507 -1.371 . . . . 0.0 113.171 172.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA3' ' CD2' ' A' ' 7' ' ' TYR . . . 2.62 79.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.754 1 C-N-CA 132.106 4.67 . . . . 0.0 118.317 170.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.85 -20.56 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.099 1.36 . . . . 0.0 112.217 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 p -103.07 -12.9 17.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.632 2.373 . . . . 0.0 114.562 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 21.1 m-30 -70.29 147.76 49.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.478 1.49 . . . . 0.0 112.696 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.8 m -65.83 151.39 46.77 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.887 1.275 . . . . 0.0 110.951 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 mmt -60.09 136.93 58.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.436 1.094 . . . . 0.0 111.452 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 39.1 m -64.66 158.5 24.37 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.173 0.589 . . . . 0.0 111.302 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -59.57 126.81 29.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.953 1.301 . . . . 0.0 110.754 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -59.6 -16.67 27.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.55 -18.18 10.42 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -80.94 15.73 1.72 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -99.17 159.95 14.61 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.964 1.306 . . . . 0.0 113.95 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -140.94 146.84 37.91 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.472 1.509 . . . . 0.0 110.513 161.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -68.48 110.2 4.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.117 1.367 . . . . 0.0 111.176 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 23.1 mtmt -69.12 -41.41 77.44 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.619 0.767 . . . . 0.0 110.148 159.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -140.76 102.14 4.23 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 127.139 2.176 . . . . 0.0 106.924 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.97 152.29 50.91 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.953 -0.546 . . . . 0.0 109.774 170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -47.54 120.36 4.47 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.87 3.047 . . . . 0.0 114.169 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -139.02 170.3 16.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.164 0.986 . . . . 0.0 111.092 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.71 145.71 34.35 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.46 0.647 . . . . 0.0 111.582 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 p -86.1 -17.96 33.67 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 -6.77 70.18 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 118.987 -0.896 . . . . 0.0 113.897 -159.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -90.33 4.64 50.2 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.252 1.526 . . . . 0.0 112.4 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 54.01 38.96 30.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 112.225 -158.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.8 p -125.59 170.44 11.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.344 1.858 . . . . 0.0 109.371 172.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 HD13 ' A' ' 79' ' ' LEU . 3.9 t -119.9 112.68 37.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.612 1.565 . . . . 0.0 109.005 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 m -101.74 139.54 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.955 1.302 . . . . 0.0 109.996 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.427 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.9 ptp -152.17 164.17 37.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.499 0.719 . . . . 0.0 110.621 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.49 142.78 20.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.167 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 88' ' ' VAL . 16.9 m -136.05 159.43 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.93 154.62 28.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.553 1.541 . . . . 0.0 109.458 160.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.6 124.31 19.73 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 111.542 -167.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -85.75 -6.27 59.14 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.763 1.225 . . . . 0.0 114.183 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.1 -166.21 39.41 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.986 0.803 . . . . 0.0 113.258 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.0 150.98 1.36 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.692 2.397 . . . . 0.0 114.033 -175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -123.08 130.77 24.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.426 1.09 . . . . 0.0 108.675 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.08 170.81 64.82 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.804 0.966 . . . . 0.0 112.231 -4.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.6 p -156.07 163.15 40.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.58 0.752 . . . . 0.0 111.377 158.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -88.98 127.59 35.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.918 1.687 . . . . 0.0 110.022 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.566 HG22 HG23 ' A' ' 45' ' ' VAL . 65.5 mt -70.47 117.81 58.6 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.74 78.09 2.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 125.044 3.83 . . . . 0.0 110.966 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -103.28 145.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 125.228 1.411 . . . . 0.0 112.518 -165.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -163.22 164.48 25.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.132 2.173 . . . . 0.0 109.209 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.26 134.31 45.13 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.695 1.198 . . . . 0.0 109.415 164.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.37 120.45 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.731 0.696 . . . . 0.0 109.896 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.34 140.15 58.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.131 0.572 . . . . 0.0 111.049 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -55.43 99.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.84 -16.84 5.53 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.439 1.495 . . . . 0.0 114.396 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.95 79.53 22.57 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 119.188 1.494 . . . . 0.0 111.916 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.41 -14.43 16.13 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 124.371 3.381 . . . . 0.0 115.432 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -25.14 36.17 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.503 2.721 . . . . 0.0 113.297 -173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.31 114.17 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 0.0 110.701 -164.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -68.83 120.77 15.28 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.477 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.0 m -104.45 1.09 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.284 1.834 . . . . 0.0 112.802 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.55 112.14 5.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.206 1.003 . . . . 0.0 112.822 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.6 mtm -97.55 96.3 8.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 168.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mp -62.85 127.45 31.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.055 0.455 . . . . 0.0 111.733 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.37 -26.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.917 1.687 . . . . 0.0 110.544 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.04 165.22 14.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.669 1.188 . . . . 0.0 110.236 166.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.84 172.57 2.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.13 2.554 . . . . 0.0 116.056 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -38.09 110.46 0.54 Allowed Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 128.306 2.642 . . . . 0.0 112.247 167.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.74 140.33 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.347 2.032 . . . . 0.0 112.561 -165.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -135.77 156.04 49.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.512 1.125 . . . . 0.0 111.849 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.63 135.03 54.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.368 1.467 . . . . 0.0 108.38 169.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -140.75 172.18 13.06 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.946 0.879 . . . . 0.0 111.851 -161.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -90.8 -7.08 53.35 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.529 1.531 . . . . 0.0 112.709 166.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -129.91 28.51 5.07 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.776 2.03 . . . . 0.0 111.629 -173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.4 -145.8 17.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.714 1.626 . . . . 0.0 111.13 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.52 175.86 44.54 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 122.548 1.082 . . . . 0.0 114.874 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.97 70.76 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 117.055 -1.97 . . . . 0.0 115.803 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -102.67 148.9 25.0 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.594 2.197 . . . . 0.0 113.502 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 45' ' ' VAL . 25.2 mt -146.95 143.74 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.12 1.768 . . . . 0.0 110.185 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -131.31 131.8 44.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.803 1.241 . . . . 0.0 110.084 159.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -141.58 164.91 28.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.78 1.632 . . . . 0.0 111.613 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.537 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.2 tt0 -124.47 149.19 47.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.683 1.193 . . . . 0.0 110.71 174.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.09 159.23 50.24 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.088 1.355 . . . . 0.0 112.039 -162.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -66.27 131.01 25.38 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.183 3.255 . . . . 0.0 111.768 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.41 138.92 23.34 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.297 3.331 . . . . 0.0 114.483 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.32 -177.88 16.62 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.685 1.136 . . . . 0.0 113.092 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.31 120.04 15.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.861 0.839 . . . . 0.0 111.341 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -125.04 120.56 31.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.341 1.456 . . . . 0.0 107.938 172.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.62 105.24 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.9 136.68 23.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.764 0.826 . . . . 0.0 108.916 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.01 148.72 42.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.792 1.237 . . . . 0.0 112.375 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 HG11 ' A' ' 33' ' ' VAL . 41.6 t -126.19 83.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.187 158.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.67 -111.07 3.59 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.82 1.2 . . . . 0.0 111.824 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -116.44 -11.96 11.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.86 1.264 . . . . 0.0 111.673 169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.81 132.34 53.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 154.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -140.94 172.18 13.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.242 1.017 . . . . 0.0 113.151 -171.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -159.6 132.59 6.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.0 1.72 . . . . 0.0 110.708 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -70.08 116.01 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.756 0.823 . . . . 0.0 110.616 169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -110.61 110.25 20.87 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.047 . . . . 0.0 110.746 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -73.92 87.97 1.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.57 1.148 . . . . 0.0 109.944 168.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -68.23 140.04 56.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.833 1.253 . . . . 0.0 112.169 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 pttp -117.98 157.67 26.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 110.77 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 C-N-CA 126.743 2.116 . . . . 0.0 109.498 -170.29 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 122.293 1.044 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.4 p -148.02 92.12 2.01 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.056 1.742 . . . . 0.0 109.174 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.65 56.85 1.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.538 1.161 . . . . 0.0 109.968 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.05 97.28 0.1 Allowed Glycine 0 C--N 1.338 0.668 0 C-N-CA 128.773 3.083 . . . . 0.0 113.104 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.3 mt -55.55 -13.42 1.55 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.239 1.816 . . . . 0.0 113.782 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 p -104.65 -8.03 19.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.678 2.391 . . . . 0.0 114.127 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.75 154.69 41.5 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.139 1.336 . . . . 0.0 112.322 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.89 158.53 27.75 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.9 1.28 . . . . 0.0 112.596 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.06 131.26 45.11 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.609 1.164 . . . . 0.0 110.84 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.9 m -67.48 147.99 52.11 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.515 0.598 . . . . 0.0 111.375 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -53.07 127.65 24.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.961 1.704 . . . . 0.0 111.088 168.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -70.68 -4.17 22.22 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.63 -23.0 3.81 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -67.36 -0.68 3.8 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -81.43 162.19 23.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.423 1.489 . . . . 0.0 114.904 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 p -147.82 139.4 23.81 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.92 2.488 . . . . 0.0 109.591 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -67.3 114.08 5.72 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 111.095 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 19.9 ttmt -85.76 -35.65 20.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.37 1.468 . . . . 0.0 110.569 172.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -146.37 107.79 4.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.244 2.618 . . . . 0.0 107.475 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.14 154.78 59.7 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.465 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.19 119.79 4.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.973 3.116 . . . . 0.0 114.455 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 169.01 18.46 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.379 1.471 . . . . 0.0 110.454 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.53 145.24 41.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.533 0.682 . . . . 0.0 110.777 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -75.96 -22.42 55.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 114.743 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.55 -1.89 64.43 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.575 -158.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.76 6.71 19.91 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.89 1.676 . . . . 0.0 113.18 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 63.13 24.06 14.23 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 112.641 -164.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.1 p -116.33 167.88 10.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.413 2.285 . . . . 0.0 108.559 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 79' ' ' LEU . 4.0 t -118.29 118.15 57.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.568 1.547 . . . . 0.0 109.078 -167.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.95 148.47 10.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.67 1.188 . . . . 0.0 110.549 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.418 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.0 ptp -158.85 167.3 29.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.702 1.201 . . . . 0.0 109.496 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.97 146.0 25.26 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.53 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 23.5 m -134.85 158.71 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.55 139.3 50.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.889 2.076 . . . . 0.0 108.475 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -135.03 114.7 12.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.479 0.712 . . . . 0.0 112.876 -161.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.08 -1.06 34.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.854 1.662 . . . . 0.0 115.269 -169.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.96 -139.07 10.39 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.626 1.108 . . . . 0.0 113.846 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 p -50.63 159.65 0.5 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.495 2.318 . . . . 0.0 115.24 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -140.97 121.88 8.92 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 126.648 1.979 . . . . 0.0 107.502 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -76.55 175.79 46.66 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 CA-C-N 120.729 1.296 . . . . 0.0 111.752 -7.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.6 p -161.99 164.8 28.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 157.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -87.95 126.48 35.08 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 129.331 3.052 . . . . 0.0 110.629 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.593 HG22 HG23 ' A' ' 45' ' ' VAL . 37.4 mt -76.06 113.85 31.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 109.385 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.16 83.79 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.449 3.433 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 HG22 ' A' ' 43' ' ' ILE . 1.1 t -108.77 145.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 112.582 -168.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -160.81 161.8 32.11 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.419 2.288 . . . . 0.0 108.905 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.11 119.57 22.12 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.884 1.273 . . . . 0.0 108.577 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.7 m -113.0 116.5 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.28 146.24 40.18 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.82 0.848 . . . . 0.0 111.873 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -53.45 104.17 0.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.0 112.785 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.25 -11.26 19.78 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.254 1.406 . . . . 0.0 114.931 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.52 77.43 59.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 119.349 1.574 . . . . 0.0 111.284 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.65 -13.58 40.49 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.615 2.876 . . . . 0.0 114.016 -172.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.57 -20.06 57.22 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.71 2.404 . . . . 0.0 113.319 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.3 t -107.77 97.21 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.547 0.739 . . . . 0.0 110.929 -166.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -65.09 128.03 34.08 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.357 166.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.69 4.6 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.584 1.954 . . . . 0.0 112.651 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 94.54 0.98 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.892 1.277 . . . . 0.0 113.623 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmt -82.3 99.3 9.26 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.901 -1.124 . . . . 0.0 109.716 168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.31 131.07 46.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.606 0.762 . . . . 0.0 111.827 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.97 -32.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.827 1.651 . . . . 0.0 110.495 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.524 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -92.01 162.88 29.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.3 162.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.38 165.66 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.471 2.114 . . . . 0.0 114.507 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.59 109.14 0.41 Allowed Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 127.149 2.18 . . . . 0.0 110.658 165.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 147.1 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.375 2.05 . . . . 0.0 113.04 -167.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.5 p -135.49 149.04 49.42 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.8 1.24 . . . . 0.0 110.758 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 142.32 35.07 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.952 1.701 . . . . 0.0 108.337 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -144.96 172.54 12.9 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.375 1.07 . . . . 0.0 110.571 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -94.66 -16.98 22.69 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.968 1.307 . . . . 0.0 112.715 166.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -115.8 27.91 8.98 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.602 1.961 . . . . 0.0 111.5 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.31 -148.89 20.87 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.739 2.114 . . . . 0.0 109.86 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.83 163.15 26.91 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 123.053 1.363 . . . . 0.0 116.1 160.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.41 -6.97 57.94 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.237 -1.868 . . . . 0.0 115.664 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -102.84 153.2 20.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.044 1.922 . . . . 0.0 114.227 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.456 ' CD1' HG21 ' A' ' 45' ' ' VAL . 52.2 mt -148.57 146.23 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 127.284 2.234 . . . . 0.0 110.346 -170.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' H ' HG22 ' A' ' 62' ' ' THR . 50.8 tt0 -135.34 130.72 35.43 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.726 1.611 . . . . 0.0 109.442 156.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 79' ' ' LEU . 13.7 ptp -140.37 165.99 25.92 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.822 1.649 . . . . 0.0 111.87 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.625 ' C ' HD12 ' A' ' 79' ' ' LEU . 34.9 tt0 -130.61 148.73 52.44 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.197 -0.94 . . . . 0.0 111.379 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.8 mp -144.71 161.96 40.93 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.524 1.929 . . . . 0.0 110.465 -160.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.9 127.42 16.1 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.843 3.029 . . . . 0.0 111.697 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.05 125.84 12.33 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 124.722 3.614 . . . . 0.0 112.089 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.13 -162.22 25.64 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -160.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -108.41 131.61 54.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.598 0.759 . . . . 0.0 111.284 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -139.61 121.99 16.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.346 1.458 . . . . 0.0 109.227 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.78 108.36 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.75 126.74 44.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 C-N-CA 124.364 1.066 . . . . 0.0 109.131 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.22 151.37 28.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 125.233 1.413 . . . . 0.0 112.368 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.6 t -131.5 94.94 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 127.101 2.16 . . . . 0.0 106.182 163.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.8 -118.68 7.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -165.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -107.54 -8.71 16.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.808 0.843 . . . . 0.0 112.922 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.65 142.25 58.11 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 162.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -146.22 172.51 13.35 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -153.81 141.26 19.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.444 1.898 . . . . 0.0 109.742 166.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -80.24 125.13 29.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.357 1.063 . . . . 0.0 110.385 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -123.88 116.51 23.04 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.99 0.9 . . . . 0.0 112.61 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -81.99 96.97 7.88 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.377 1.871 . . . . 0.0 109.748 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -77.56 141.39 39.58 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.88 1.672 . . . . 0.0 112.693 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -114.43 160.66 18.92 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.156 1.382 . . . . 0.0 111.403 167.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 127.359 2.409 . . . . 0.0 109.981 -173.244 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.8 mm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 m -54.17 103.97 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.157 1.783 . . . . 0.0 113.146 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -56.78 114.85 2.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.926 2.091 . . . . 0.0 110.129 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.8 88.99 1.58 Allowed Glycine 0 N--CA 1.462 0.412 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -165.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 mp -56.9 -18.55 13.64 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 0.0 112.768 168.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -107.48 -12.57 15.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 114.945 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.42 150.28 43.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.613 1.551 . . . . 0.0 111.823 -171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 m -68.02 151.83 46.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 111.222 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.7 mmt -60.41 135.0 57.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.044 0.938 . . . . 0.0 112.04 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -66.58 152.0 46.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.368 0.667 . . . . 0.0 111.295 170.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -56.06 124.18 16.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.705 1.602 . . . . 0.0 111.426 168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -62.71 -12.22 22.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.84 -13.9 9.49 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -172.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 44.2 mmtm -80.78 -2.61 47.81 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.116 1.325 . . . . 0.0 114.337 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -79.9 158.42 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.287 1.835 . . . . 0.0 114.955 -174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -142.96 150.11 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.281 2.232 . . . . 0.0 109.815 168.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -74.49 115.83 14.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.012 0.925 . . . . 0.0 111.17 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.2 ttmt -84.62 -35.38 22.74 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.233 1.413 . . . . 0.0 110.582 170.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -145.61 110.3 5.1 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.344 2.658 . . . . 0.0 107.667 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.78 151.7 78.26 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.146 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.28 117.46 2.28 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.245 3.297 . . . . 0.0 114.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -133.26 161.62 33.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.348 1.859 . . . . 0.0 110.14 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 15.1 t0 -60.59 143.27 54.23 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 162.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 p -77.16 -25.87 52.38 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.017 2.527 . . . . 0.0 113.777 169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 99.98 -1.25 56.43 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.513 1.53 . . . . 0.0 112.859 -160.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -104.83 5.12 32.85 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 112.913 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 59.82 30.75 20.31 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.653 1.181 . . . . 0.0 112.213 -159.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.6 p -121.59 157.34 30.99 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.931 1.692 . . . . 0.0 108.979 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.54 112.95 42.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.417 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.06 141.45 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 124.686 1.194 . . . . 0.0 110.173 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 ptp -150.36 167.53 26.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.933 0.893 . . . . 0.0 110.198 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -152.6 145.84 24.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.113 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 14.1 m -134.55 158.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.1 133.43 50.42 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.902 2.081 . . . . 0.0 108.399 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 61.9 t80 -129.54 125.74 36.97 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.781 0.833 . . . . 0.0 112.585 -157.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -83.19 -3.08 57.02 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.077 1.351 . . . . 0.0 114.073 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.42 -160.34 26.08 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.493 1.52 . . . . 0.0 113.862 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -48.43 152.05 0.98 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.663 2.385 . . . . 0.0 115.111 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -136.39 113.97 10.42 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.132 1.773 . . . . 0.0 108.329 172.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.67 164.96 71.97 Favored 'Cis proline' 0 CA--C 1.538 0.723 0 CA-C-N 120.577 1.242 . . . . 0.0 113.894 7.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.9 p -156.12 166.94 31.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.129 0.971 . . . . 0.0 111.858 157.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 66' ' ' THR . 9.6 ttm180 -98.83 127.35 44.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.738 2.415 . . . . 0.0 110.857 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.3 mt -74.03 116.9 56.86 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 109.44 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.94 76.86 1.99 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.769 3.646 . . . . 0.0 110.709 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.444 ' CG2' HG22 ' A' ' 88' ' ' VAL . 1.2 t -107.91 143.71 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 124.818 1.247 . . . . 0.0 111.995 -168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -159.22 155.97 28.0 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.92 1.688 . . . . 0.0 109.474 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.8 128.35 55.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.87 115.35 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.178 0.899 . . . . 0.0 110.3 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.97 150.98 43.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.289 0.636 . . . . 0.0 111.785 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -56.62 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.299 1.439 . . . . 0.0 112.923 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.35 -19.85 2.26 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.495 1.522 . . . . 0.0 114.742 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 86.16 16.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.112 1.456 . . . . 0.0 110.52 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.56 -0.48 9.82 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.364 3.376 . . . . 0.0 115.263 -167.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -102.84 -43.38 5.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.118 2.967 . . . . 0.0 112.086 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.83 105.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.95 126.63 28.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 0.0 111.59 168.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.4 1.63 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 126.757 2.023 . . . . 0.0 112.508 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.17 107.67 6.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.354 1.062 . . . . 0.0 113.45 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.5 ttt -75.83 100.39 4.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.87 -1.144 . . . . 0.0 108.898 159.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.19 126.37 27.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.827 -0.545 . . . . 0.0 110.873 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.77 -36.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.203 1.801 . . . . 0.0 110.2 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -86.57 162.28 45.62 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.997 162.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.81 169.59 7.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.68 2.253 . . . . 0.0 115.606 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -32.92 103.89 0.22 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 128.727 2.811 . . . . 0.0 112.243 168.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.69 137.21 17.85 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.118 2.545 . . . . 0.0 112.759 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 42' ' ' ARG . 7.6 p -134.49 158.4 44.03 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.637 1.575 . . . . 0.0 111.168 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.32 120.62 34.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.274 1.83 . . . . 0.0 106.947 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -128.85 161.01 30.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.856 0.836 . . . . 0.0 111.179 -155.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -81.63 -3.69 54.14 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.721 0.808 . . . . 0.0 112.124 168.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -130.02 24.81 5.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.082 2.153 . . . . 0.0 111.984 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.21 -145.23 16.36 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.965 1.269 . . . . 0.0 112.608 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.04 -176.68 42.5 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 123.154 1.419 . . . . 0.0 115.32 166.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.86 -6.97 70.14 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 117.168 -1.907 . . . . 0.0 114.798 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -105.87 147.12 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.056 1.928 . . . . 0.0 114.302 -170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -147.22 144.41 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 110.344 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' H ' HG22 ' A' ' 62' ' ' THR . 57.7 tt0 -133.9 133.0 40.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.616 1.566 . . . . 0.0 109.1 160.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.452 ' SD ' HD11 ' A' ' 79' ' ' LEU . 14.4 ptp -143.17 167.66 21.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.992 1.717 . . . . 0.0 111.764 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.626 ' C ' HD12 ' A' ' 79' ' ' LEU . 35.5 tt0 -131.2 147.93 52.65 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.52 1.128 . . . . 0.0 111.27 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 78' ' ' GLN . 7.9 mp -141.94 160.83 54.21 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.292 1.837 . . . . 0.0 110.631 -159.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.88 130.43 16.78 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.47 2.78 . . . . 0.0 111.586 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.48 122.07 4.45 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.947 3.765 . . . . 0.0 113.595 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.47 -179.58 18.99 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.476 1.036 . . . . 0.0 113.727 -171.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -71.29 114.74 9.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.286 1.434 . . . . 0.0 111.188 174.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -126.4 119.56 27.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.682 1.593 . . . . 0.0 108.971 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.66 110.03 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.0 mt -96.3 117.65 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -103.19 146.01 29.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.977 0.911 . . . . 0.0 111.771 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 45' ' ' VAL . 72.2 t -120.64 93.54 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 156.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.62 2.77 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -117.54 -12.28 10.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.533 1.533 . . . . 0.0 112.054 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.28 136.49 57.95 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 161.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -134.68 173.11 12.04 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -146.7 149.08 32.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.698 1.999 . . . . 0.0 109.208 165.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -94.97 106.54 18.54 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.697 1.199 . . . . 0.0 109.019 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -107.72 131.55 54.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.583 0.706 . . . . 0.0 112.144 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -107.06 88.7 2.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.219 1.408 . . . . 0.0 108.726 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -70.47 130.93 43.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.442 0.697 . . . . 0.0 112.404 -165.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -109.01 130.49 55.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.034 2.134 . . . . 0.0 107.778 166.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 C-N-CA 127.069 2.271 . . . . 0.0 109.337 173.183 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.7 mm . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.929 -0.558 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m -55.33 145.98 20.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.518 1.127 . . . . 0.0 113.905 -171.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -106.61 95.98 6.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.021 1.329 . . . . 0.0 110.272 -173.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -77.83 88.13 1.06 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.531 1.062 . . . . 0.0 114.82 -171.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.1 mt -55.58 -20.16 12.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.154 1.382 . . . . 0.0 113.138 164.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -105.6 -14.38 15.3 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.178 1.791 . . . . 0.0 114.864 -170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 11.4 m-30 -69.38 159.79 32.52 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.933 1.242 . . . . 0.0 113.402 -171.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 p -64.55 160.16 20.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.199 1.799 . . . . 0.0 112.092 168.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.14 143.87 47.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.559 0.743 . . . . 0.0 111.816 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 35.3 m -74.01 151.08 40.35 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.085 0.554 . . . . 0.0 111.777 171.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.85 113.97 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.333 1.853 . . . . 0.0 112.045 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -57.93 -12.58 3.35 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.03 -6.96 11.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.439 1.495 . . . . 0.0 114.768 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -94.76 8.01 43.96 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.985 1.266 . . . . 0.0 113.275 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -83.28 159.49 21.91 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.8 p -147.0 140.35 25.48 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.871 2.068 . . . . 0.0 110.193 174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -68.46 110.02 3.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.268 1.027 . . . . 0.0 110.911 173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 21.9 ttmt -79.43 -36.27 39.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.818 1.247 . . . . 0.0 110.132 168.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -148.51 107.19 3.81 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 128.027 2.531 . . . . 0.0 107.642 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.2 153.26 75.73 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.752 -0.592 . . . . 0.0 111.331 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.45 122.1 5.35 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 124.414 3.41 . . . . 0.0 114.704 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -141.17 159.04 43.06 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.728 1.611 . . . . 0.0 110.392 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.13 139.42 56.16 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.2 p -79.66 -20.16 47.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.495 1.918 . . . . 0.0 114.56 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -6.58 83.19 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.693 1.14 . . . . 0.0 113.658 -161.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -91.13 4.73 51.44 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.394 1.478 . . . . 0.0 112.642 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 62.06 29.72 17.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.511 1.524 . . . . 0.0 112.617 -162.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.9 p -121.71 166.43 14.3 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.477 1.911 . . . . 0.0 109.36 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 79' ' ' LEU . 4.3 t -113.11 110.6 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.528 1.531 . . . . 0.0 109.041 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.86 143.82 12.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 123.522 0.729 . . . . 0.0 109.97 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.485 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.1 ptp -155.9 168.62 26.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.981 0.913 . . . . 0.0 109.962 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.82 147.22 23.99 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 111.216 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 16.3 m -134.85 156.0 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 122.089 0.947 . . . . 0.0 113.296 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.31 146.96 42.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.214 1.406 . . . . 0.0 108.55 163.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 10' ' ' CYS . 32.0 t80 -134.96 117.18 15.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.764 0.826 . . . . 0.0 111.321 -163.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -87.89 1.83 53.04 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.38 -152.11 26.82 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.101 0.864 . . . . 0.0 112.635 173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -49.41 161.86 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.421 1.888 . . . . 0.0 114.439 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.45 139.07 28.5 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 153.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . 35.9 Cg_endo -76.4 167.65 79.49 Favored 'Cis proline' 0 CA--C 1.538 0.709 0 CA-C-N 119.776 0.956 . . . . 0.0 111.791 -4.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -161.15 164.0 30.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 161.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttm-85 -91.58 128.45 37.41 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.154 2.181 . . . . 0.0 110.149 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 45' ' ' VAL . 88.0 mt -74.1 120.41 81.22 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.813 0.845 . . . . 0.0 108.833 -175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.17 77.19 3.25 Favored 'Trans proline' 0 C--N 1.353 0.79 1 C-N-CA 125.412 4.075 . . . . 0.0 110.016 -176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.66 HG23 HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -107.07 133.84 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.752 1.621 . . . . 0.0 111.664 -166.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.77 159.42 38.28 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.692 1.597 . . . . 0.0 109.561 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -124.16 126.36 46.02 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 107.862 166.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.91 123.25 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.944 0.793 . . . . 0.0 109.409 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.17 160.87 29.3 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -167.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -41.97 103.51 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.298 1.839 . . . . 0.0 114.209 -175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.02 -17.4 32.19 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 117.774 -1.57 . . . . 0.0 115.891 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 92.64 20.73 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 120.104 1.952 . . . . 0.0 113.077 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.21 -6.56 15.76 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.545 2.83 . . . . 0.0 115.128 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.55 -29.73 63.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.381 2.272 . . . . 0.0 112.598 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -109.73 102.58 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.455 1.102 . . . . 0.0 110.233 -163.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -69.59 110.18 4.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 111.456 170.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 47' ' ' ALA . 16.5 m -88.87 -0.08 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.09 2.156 . . . . 0.0 113.341 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.23 136.5 55.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.792 1.178 . . . . 0.0 113.146 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 43.7 ttp -118.47 94.02 4.33 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.952 1.301 . . . . 0.0 108.846 169.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.67 126.82 28.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.349 0.522 . . . . 0.0 111.707 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -98.0 -18.32 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 126.525 1.93 . . . . 0.0 110.506 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -110.37 172.74 3.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.072 1.749 . . . . 0.0 109.828 166.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 169.35 2.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.963 2.442 . . . . 0.0 115.692 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.82 105.26 0.42 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.201 2.6 . . . . 0.0 111.014 160.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.38 138.67 30.46 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.292 1.995 . . . . 0.0 113.116 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 4' ' ' GLY . 19.6 p -126.61 159.71 32.79 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.882 1.273 . . . . 0.0 112.172 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 127.7 51.87 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.472 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.71 159.45 30.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.083 1.353 . . . . 0.0 110.642 -162.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -73.91 -10.25 59.46 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.954 -1.091 . . . . 0.0 112.895 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -131.34 33.46 4.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.035 2.134 . . . . 0.0 112.185 -174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.52 -152.44 23.4 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.507 1.051 . . . . 0.0 112.287 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.29 178.34 30.11 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 122.875 1.264 . . . . 0.0 115.278 168.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.39 48.39 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.173 -1.904 . . . . 0.0 116.751 171.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -106.85 151.38 25.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.616 2.208 . . . . 0.0 114.846 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.574 ' CD1' HG21 ' A' ' 45' ' ' VAL . 16.5 mt -148.41 140.37 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 126.663 1.985 . . . . 0.0 110.938 -169.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 62' ' ' THR . 51.9 tt0 -131.14 132.87 45.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 0.0 108.788 154.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.3 ptp -140.72 162.47 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.714 1.605 . . . . 0.0 110.326 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 79' ' ' LEU . 36.9 tt0 -120.74 154.24 35.91 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.019 0.928 . . . . 0.0 110.16 171.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.5 mp -145.7 153.23 50.46 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.356 1.062 . . . . 0.0 111.92 -162.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.64 122.94 12.69 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.604 3.536 . . . . 0.0 112.378 165.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -54.3 141.56 70.87 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.885 3.057 . . . . 0.0 114.144 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.76 -163.77 12.44 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.16 0.886 . . . . 0.0 111.91 -163.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -88.74 113.38 24.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.383 1.473 . . . . 0.0 112.206 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -122.14 134.63 54.74 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.778 1.231 . . . . 0.0 109.944 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.07 105.97 18.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.2 mt -93.51 114.98 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.95 143.56 30.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.418 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 33' ' ' VAL . 53.1 t -116.51 96.08 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.069 152.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -116.67 4.67 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.26 -6.51 17.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.242 1.017 . . . . 0.0 112.114 168.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.41 119.79 14.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.599 0.76 . . . . 0.0 109.036 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -108.67 166.33 10.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.708 0.803 . . . . 0.0 112.691 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -142.54 141.89 32.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.099 1.36 . . . . 0.0 109.069 153.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -80.76 106.04 12.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -106.19 105.94 16.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.115 0.959 . . . . 0.0 111.753 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.82 113.24 20.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.896 169.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -98.1 138.38 35.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.033 1.733 . . . . 0.0 113.602 -163.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptp -109.06 130.78 55.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.518 2.327 . . . . 0.0 108.52 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 116.822 -2.099 . . . . 0.0 109.665 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.489 ' HA ' ' OE1' ' A' ' 68' ' ' GLU 0.276 14.6 tt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.813 0.339 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t 59.94 -164.91 0.21 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.095 2.558 . . . . 0.0 116.102 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -84.21 74.18 10.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.266 2.226 . . . . 0.0 111.944 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.27 124.47 6.67 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.524 1.059 . . . . 0.0 113.246 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.7 -11.58 27.12 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.552 1.541 . . . . 0.0 113.529 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.74 -11.84 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.278 1.431 . . . . 0.0 114.758 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -66.45 149.76 49.94 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.958 1.254 . . . . 0.0 111.701 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 p -72.4 162.32 29.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.634 0.731 . . . . 0.0 111.72 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.3 mmt -68.43 134.6 50.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.706 0.802 . . . . 0.0 110.876 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.7 m -62.64 147.96 47.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.872 0.368 . . . . 0.0 110.492 167.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -54.49 124.73 17.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.757 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -57.36 -17.98 15.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.48 -4.12 9.34 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -170.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -89.28 -0.34 57.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 119.821 1.191 . . . . 0.0 114.054 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.86 158.4 26.74 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.425 1.49 . . . . 0.0 114.922 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.9 p -142.31 143.03 32.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.965 2.106 . . . . 0.0 109.804 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -70.52 107.88 4.06 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.278 1.031 . . . . 0.0 110.298 173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.31 -34.57 36.67 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.085 0.954 . . . . 0.0 110.517 171.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -143.12 102.49 4.0 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 128.173 2.589 . . . . 0.0 107.475 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 151.98 77.73 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.409 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.99 123.21 11.33 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.231 3.287 . . . . 0.0 115.403 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -144.39 167.25 22.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.842 0.857 . . . . 0.0 112.703 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.09 139.1 44.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.495 1.118 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.4 p -80.81 -4.34 54.32 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -0.95 59.99 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-N 119.263 0.938 . . . . 0.0 113.652 -165.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -118.81 17.75 13.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.321 1.848 . . . . 0.0 111.498 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 59.3 22.78 11.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.436 1.894 . . . . 0.0 113.329 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.5 p -110.37 167.72 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.101 1.76 . . . . 0.0 109.174 167.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.21 114.17 38.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.404 1.482 . . . . 0.0 108.86 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 m -102.58 144.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.293 1.437 . . . . 0.0 110.784 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.499 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.4 ptp -155.2 166.65 32.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.325 1.05 . . . . 0.0 110.732 174.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -153.12 150.15 28.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.301 0.64 . . . . 0.0 111.481 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 88' ' ' VAL . 19.4 m -133.61 165.41 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 145.98 50.8 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.878 2.071 . . . . 0.0 108.863 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -138.05 125.79 22.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -159.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.87 0.85 56.19 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.968 1.307 . . . . 0.0 114.106 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.6 -157.0 20.0 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.201 1.382 . . . . 0.0 113.92 -177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.2 145.76 1.03 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 128.215 2.606 . . . . 0.0 114.654 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -132.96 124.9 18.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.115 -0.945 . . . . 0.0 108.609 169.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -79.06 166.07 79.91 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.714 1.291 . . . . 0.0 111.555 2.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 p -156.27 158.08 36.88 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.195 0.522 . . . . 0.0 111.907 161.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.0 ttm-85 -82.32 129.28 34.83 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.036 1.734 . . . . 0.0 109.347 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.639 HG22 HG23 ' A' ' 45' ' ' VAL . 45.2 mt -74.27 115.43 43.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.14 88.62 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.777 1 C-N-CA 125.381 4.054 . . . . 0.0 110.402 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 43' ' ' ILE . 1.5 t -118.23 139.94 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.594 1.158 . . . . 0.0 111.993 -163.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -161.52 160.64 29.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.78 2.032 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.82 115.66 20.36 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.294 1.438 . . . . 0.0 107.796 163.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.3 m -105.77 118.37 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 118.35 0.523 . . . . 0.0 109.607 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.4 147.91 52.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.197 0.522 . . . . 0.0 111.549 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -51.79 97.47 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.53 1.532 . . . . 0.0 112.961 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.5 -11.65 8.46 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.445 1.498 . . . . 0.0 115.283 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.5 77.59 52.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 119.79 1.795 . . . . 0.0 112.506 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.31 -21.94 46.78 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.929 3.086 . . . . 0.0 114.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.55 -27.87 63.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.517 2.727 . . . . 0.0 113.429 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -108.31 102.1 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.537 0.735 . . . . 0.0 110.53 -164.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.71 122.17 15.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.058 163.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.9 m -106.34 3.53 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.229 1.811 . . . . 0.0 112.724 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.71 138.01 54.57 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.225 0.921 . . . . 0.0 112.397 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 54.0 mtm -121.09 91.59 3.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.309 1.443 . . . . 0.0 108.204 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.43 119.57 9.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.65 1.58 . . . . 0.0 111.695 -171.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -90.41 -34.48 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.61 1.564 . . . . 0.0 111.007 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 76' ' ' GLU . 14.6 t -86.77 151.47 52.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.167 158.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.38 167.27 3.74 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.524 2.149 . . . . 0.0 115.053 175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -29.18 98.68 0.1 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 130.165 3.386 . . . . 0.0 111.959 170.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.14 144.94 38.41 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.191 1.927 . . . . 0.0 113.291 -168.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.6 p -127.98 154.83 45.16 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.871 1.268 . . . . 0.0 111.583 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.18 117.98 35.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 165.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 1' ' ' ILE . 3.7 tp10 -103.29 158.42 16.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 110.589 -160.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -57.37 -21.91 39.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.38 26.88 1.28 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.022 0.929 . . . . 0.0 112.172 175.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.0 -157.93 19.15 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.342 -0.848 . . . . 0.0 113.755 -172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.9 -170.57 32.1 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 121.911 0.729 . . . . 0.0 114.549 168.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.2 -6.52 36.78 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 116.894 -2.059 . . . . 0.0 116.3 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -96.98 137.9 35.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.46 2.13 . . . . 0.0 115.738 -168.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.547 HD13 HG21 ' A' ' 45' ' ' VAL . 27.4 mt -140.44 139.9 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.608 1.963 . . . . 0.0 110.085 -171.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.69 ' H ' HG22 ' A' ' 62' ' ' THR . 85.5 tt0 -133.86 132.62 40.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.146 2.179 . . . . 0.0 107.869 161.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.479 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.9 ptp -140.41 157.55 45.36 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.033 1.333 . . . . 0.0 110.441 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' C ' HD12 ' A' ' 79' ' ' LEU . 28.1 tt0 -113.47 151.14 31.85 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.695 0.798 . . . . 0.0 110.029 168.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.554 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -145.23 150.7 45.86 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.328 1.051 . . . . 0.0 110.635 -166.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.79 127.35 22.25 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 122.717 2.278 . . . . 0.0 110.735 166.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.44 151.59 6.86 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.508 3.472 . . . . 0.0 114.319 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.56 -149.95 17.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.041 0.829 . . . . 0.0 112.257 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -104.3 120.01 40.23 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.163 0.985 . . . . 0.0 110.391 174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -127.62 122.07 32.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.243 1.017 . . . . 0.0 109.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mp -82.14 99.75 5.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -84.85 130.76 35.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.812 0.845 . . . . 0.0 109.23 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -115.36 146.83 41.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.708 1.603 . . . . 0.0 112.003 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 73.3 t -128.24 88.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.673 -1.603 . . . . 0.0 106.774 155.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.69 -120.21 5.84 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.316 0.96 . . . . 0.0 111.757 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -112.01 -6.82 14.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.56 1.144 . . . . 0.0 111.828 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.14 127.07 29.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.722 1.209 . . . . 0.0 108.838 158.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -137.41 172.2 13.33 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.541 1.136 . . . . 0.0 113.636 -167.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -162.37 121.79 2.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.503 1.921 . . . . 0.0 110.726 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.21 114.09 4.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.467 -0.771 . . . . 0.0 110.154 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -104.39 112.58 25.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.755 0.822 . . . . 0.0 110.141 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -79.05 110.04 13.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.621 1.168 . . . . 0.0 109.126 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.45 130.01 52.38 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.913 1.685 . . . . 0.0 111.078 -156.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -117.79 150.77 38.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.446 1.498 . . . . 0.0 111.974 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 C-N-CA 126.8 2.143 . . . . 0.0 109.901 -169.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.2 mm . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -49.7 95.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.229 1.812 . . . . 0.0 115.393 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -74.23 56.69 0.64 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.076 -1.64 . . . . 0.0 110.068 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.23 118.71 12.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 127.63 2.538 . . . . 0.0 114.132 -167.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.78 -6.76 6.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.453 1.501 . . . . 0.0 113.989 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.1 p -107.13 -19.89 13.47 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.565 1.946 . . . . 0.0 114.684 -167.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -74.23 153.18 39.54 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.147 1.34 . . . . 0.0 112.814 -171.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -69.95 165.03 22.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.337 0.655 . . . . 0.0 111.944 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.8 mmt -73.78 143.03 46.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.371 1.068 . . . . 0.0 111.78 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 46.5 m -69.85 155.31 40.75 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.04 0.536 . . . . 0.0 111.998 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -61.09 115.52 3.83 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 111.066 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -57.15 -14.05 3.65 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.13 0.99 13.12 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.294 1.438 . . . . 0.0 114.714 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.72 15.67 27.49 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.918 1.236 . . . . 0.0 113.673 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -92.6 159.46 15.46 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.9 p -141.23 140.87 34.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.478 2.311 . . . . 0.0 109.263 172.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -71.86 105.18 3.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.592 0.757 . . . . 0.0 110.423 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.0 ttmt -70.96 -34.33 71.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.564 1.145 . . . . 0.0 110.179 169.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -155.58 111.08 3.03 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.348 2.659 . . . . 0.0 108.521 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.17 156.21 69.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 O-C-N 121.953 -0.467 . . . . 0.0 111.978 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.48 120.79 4.8 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.657 3.571 . . . . 0.0 114.763 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -139.39 165.26 27.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.727 1.211 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -66.79 131.41 45.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.675 1.19 . . . . 0.0 109.791 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.0 p -75.29 -6.91 52.29 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.2 89.1 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.496 1.046 . . . . 0.0 113.536 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -121.93 13.92 10.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.603 1.561 . . . . 0.0 112.515 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 62.89 16.34 9.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.791 1.636 . . . . 0.0 113.23 -170.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.7 p -107.54 170.97 7.65 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.026 170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -124.19 117.53 51.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.176 1.39 . . . . 0.0 109.026 -166.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 m -107.5 144.73 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.422 1.089 . . . . 0.0 110.542 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.419 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 7.6 ptp -156.94 167.54 30.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.583 1.153 . . . . 0.0 110.371 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -152.72 141.98 21.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.942 0.497 . . . . 0.0 111.825 -175.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 24.3 m -133.99 159.02 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.65 147.29 52.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.101 1.76 . . . . 0.0 109.273 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -143.05 113.65 7.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -152.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -75.13 3.36 8.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.519 1.928 . . . . 0.0 114.935 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.36 -147.7 22.09 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.584 1.088 . . . . 0.0 113.807 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.98 162.2 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.811 2.445 . . . . 0.0 115.289 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -143.29 123.25 7.75 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.625 1.97 . . . . 0.0 107.513 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.32 170.82 70.76 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 120.79 1.318 . . . . 0.0 111.658 -6.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.0 p -156.18 162.7 40.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.367 0.603 . . . . 0.0 111.729 157.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -91.22 128.08 36.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.371 2.268 . . . . 0.0 109.5 172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.4 mt -73.63 117.49 61.27 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.2 81.65 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 110.06 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 75' ' ' ILE . 1.1 t -113.3 140.16 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 C-N-CA 124.767 1.227 . . . . 0.0 111.893 -167.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -159.14 160.55 35.71 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.299 1.84 . . . . 0.0 109.428 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.22 125.71 41.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.727 1.211 . . . . 0.0 108.248 166.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -116.53 118.93 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.72 0.691 . . . . 0.0 109.882 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.16 152.5 45.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.367 0.603 . . . . 0.0 112.432 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -54.78 92.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.297 1.839 . . . . 0.0 112.139 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.84 -15.75 5.11 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.934 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.87 82.17 9.47 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 119.622 1.711 . . . . 0.0 113.073 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.55 -22.04 15.75 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.184 3.256 . . . . 0.0 114.295 168.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.54 -19.64 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 129.471 3.108 . . . . 0.0 113.784 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 t -121.55 110.01 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.059 0.943 . . . . 0.0 110.527 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -67.43 115.56 7.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.889 0.376 . . . . 0.0 110.2 160.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.06 2.89 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.816 1.647 . . . . 0.0 112.641 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.8 113.97 8.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.287 0.949 . . . . 0.0 112.395 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 51.9 mtp -101.14 98.54 8.95 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.53 128.93 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.792 0.837 . . . . 0.0 111.564 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.16 -29.16 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.144 1.377 . . . . 0.0 110.624 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.6 OUTLIER -101.3 158.79 31.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.069 0.948 . . . . 0.0 109.863 165.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.57 159.78 22.82 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.522 2.148 . . . . 0.0 115.169 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -22.29 97.82 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 129.966 3.307 . . . . 0.0 113.053 162.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.6 148.8 23.35 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.878 1.718 . . . . 0.0 113.368 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -136.02 155.28 50.46 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.955 1.302 . . . . 0.0 111.234 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.19 125.48 51.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.99 1.716 . . . . 0.0 107.33 173.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.47 163.52 29.2 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 122.293 1.044 . . . . 0.0 112.82 -157.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -74.71 -13.13 60.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.548 1.539 . . . . 0.0 113.39 163.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -125.33 25.97 6.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.379 1.871 . . . . 0.0 112.031 -172.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.78 -141.88 13.32 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.475 1.512 . . . . 0.0 111.646 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -177.65 39.56 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 123.147 1.415 . . . . 0.0 115.111 167.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.38 -17.55 59.08 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 117.507 -1.719 . . . . 0.0 114.975 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -90.76 147.97 22.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.597 1.699 . . . . 0.0 114.182 -172.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 61.7 mt -148.18 144.53 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.456 1.902 . . . . 0.0 109.929 -169.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 62' ' ' THR . 70.6 tt0 -133.87 133.9 42.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.305 1.442 . . . . 0.0 109.784 158.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.495 ' SD ' HD11 ' A' ' 79' ' ' LEU . 15.0 ptp -142.1 161.97 36.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.836 1.655 . . . . 0.0 111.347 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.612 ' C ' HD12 ' A' ' 79' ' ' LEU . 33.8 tt0 -121.42 149.53 42.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.785 0.834 . . . . 0.0 110.666 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.9 mp -139.85 160.49 60.61 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.996 1.718 . . . . 0.0 109.729 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.28 124.79 17.16 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.453 3.435 . . . . 0.0 112.815 165.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.91 125.45 11.49 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.404 3.402 . . . . 0.0 112.163 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.38 -164.05 25.12 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 121.395 0.441 . . . . 0.0 112.131 -164.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -100.85 123.35 44.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.941 1.296 . . . . 0.0 110.829 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -133.85 127.75 33.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.885 1.274 . . . . 0.0 110.214 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.6 mp -88.46 109.41 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.09 124.88 46.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 108.932 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.82 145.47 40.56 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.249 1.42 . . . . 0.0 111.978 -173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG21 HG11 ' A' ' 33' ' ' VAL . 44.1 t -125.58 93.86 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 126.956 2.102 . . . . 0.0 106.211 163.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.16 -114.25 5.67 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -167.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.82 -13.72 14.42 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.832 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.13 139.87 58.01 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 160.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.41 170.93 14.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.02 0.528 . . . . 0.0 112.306 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -151.89 149.77 29.32 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.276 1.83 . . . . 0.0 108.819 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -86.29 143.4 27.92 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.658 -0.651 . . . . 0.0 110.425 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -137.74 111.75 8.4 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.718 0.77 . . . . 0.0 112.888 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -76.25 96.99 4.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.572 1.549 . . . . 0.0 109.7 164.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -79.57 134.93 36.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.637 1.175 . . . . 0.0 111.637 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -111.92 156.66 21.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.28 1.032 . . . . 0.0 111.082 162.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.45 2.453 . . . . 0.0 109.882 -171.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -46.11 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.18 2.592 . . . . 0.0 116.227 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -75.63 32.88 0.11 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.469 1.908 . . . . 0.0 113.141 170.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -43.68 113.47 0.74 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.893 3.139 . . . . 0.0 115.929 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.24 -7.19 5.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.626 1.57 . . . . 0.0 114.209 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.1 p -122.67 0.62 9.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.362 1.465 . . . . 0.0 114.744 -172.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -66.43 153.01 43.92 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.05 1.296 . . . . 0.0 111.738 170.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 t -70.02 167.59 17.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.693 0.797 . . . . 0.0 111.831 172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.5 mmt -78.57 142.89 36.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 111.467 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 54.3 m -70.65 148.34 48.18 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.039 0.536 . . . . 0.0 111.767 171.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.11 118.21 5.6 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.357 1.463 . . . . 0.0 111.894 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -55.19 -18.37 5.81 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 11.65 20.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.753 1.621 . . . . 0.0 114.096 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -112.58 1.79 15.95 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -82.22 155.76 24.74 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 67.9 p -141.57 142.31 33.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.985 2.114 . . . . 0.0 109.042 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -70.75 107.65 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.448 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 20.9 ttmt -77.62 -35.19 52.96 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.014 1.325 . . . . 0.0 110.337 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -146.82 108.5 4.33 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.977 2.511 . . . . 0.0 107.472 172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 154.0 47.67 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.636 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.72 126.06 19.95 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.169 2.58 . . . . 0.0 113.89 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -143.06 160.29 40.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.984 1.314 . . . . 0.0 110.598 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.17 149.62 50.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.886 0.474 . . . . 0.0 111.224 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.5 p -86.6 -18.72 30.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.952 1.701 . . . . 0.0 114.676 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.99 -6.98 79.22 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.328 0.966 . . . . 0.0 113.773 -160.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -100.51 5.5 44.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.591 1.556 . . . . 0.0 112.923 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 59.07 27.35 16.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.687 1.195 . . . . 0.0 112.213 -163.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.8 p -109.31 165.83 11.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.852 2.061 . . . . 0.0 108.433 166.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.61 115.89 48.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 125.531 1.532 . . . . 0.0 109.123 -169.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.7 m -99.65 148.63 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.554 1.142 . . . . 0.0 110.38 174.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 ptp -154.92 169.59 23.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.07 0.948 . . . . 0.0 110.095 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -154.57 147.45 24.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 88' ' ' VAL . 15.8 m -135.11 159.89 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -120.91 131.82 54.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.569 1.948 . . . . 0.0 108.435 167.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 64.1 t80 -124.51 133.21 53.4 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.369 1.068 . . . . 0.0 112.651 -162.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -96.54 0.34 49.97 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -167.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.94 -160.48 21.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.941 1.258 . . . . 0.0 113.515 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.42 133.09 13.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 128.111 2.564 . . . . 0.0 114.283 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -108.81 129.45 23.93 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.877 -1.059 . . . . 0.0 108.544 168.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.33 167.85 66.64 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 CA-C-N 119.944 1.016 . . . . 0.0 112.146 -1.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 p -154.57 160.15 41.32 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 162.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -88.23 134.48 33.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 170.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' HG13 ' A' ' 88' ' ' VAL . 38.9 mt -75.73 117.95 67.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.344 0.658 . . . . 0.0 109.656 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.47 84.51 1.56 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 125.06 3.84 . . . . 0.0 109.528 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -119.79 139.75 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.161 -163.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -162.83 161.18 25.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.044 1.738 . . . . 0.0 109.414 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.65 135.83 49.0 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.565 1.146 . . . . 0.0 108.946 167.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.58 120.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 118.74 0.7 . . . . 0.0 110.255 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.82 41.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.163 0.585 . . . . 0.0 111.961 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -49.72 98.44 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.948 1.699 . . . . 0.0 113.672 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.0 -19.57 5.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.422 . . . . 0.0 114.881 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.94 83.85 15.8 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.366 1.583 . . . . 0.0 112.47 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -65.8 -12.41 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.119 2.546 . . . . 0.0 113.731 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.14 -20.96 60.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.437 2.695 . . . . 0.0 113.22 176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.5 t -115.43 109.57 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.936 0.894 . . . . 0.0 110.694 -165.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.33 128.8 37.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.212 166.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.71 0.78 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.404 1.882 . . . . 0.0 112.779 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.63 6.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.459 1.104 . . . . 0.0 112.882 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -98.38 98.97 10.13 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 164.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.56 121.06 10.63 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.742 1.217 . . . . 0.0 111.564 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mm -91.3 -30.08 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.227 1.811 . . . . 0.0 110.74 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -93.68 165.51 17.88 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.639 0.776 . . . . 0.0 110.239 166.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.34 171.14 1.94 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 115.52 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -39.51 106.16 0.39 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.927 2.491 . . . . 0.0 111.852 168.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.2 135.74 17.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.374 2.05 . . . . 0.0 112.209 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -130.13 155.44 46.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.872 1.269 . . . . 0.0 111.035 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.61 137.76 53.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.002 1.321 . . . . 0.0 108.692 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -145.78 -177.15 5.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.982 1.313 . . . . 0.0 110.333 -156.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -100.25 -35.7 9.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.192 1.797 . . . . 0.0 111.67 165.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -89.2 33.49 0.8 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 112.105 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.81 -145.14 15.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.541 1.543 . . . . 0.0 111.185 -173.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.99 169.8 38.17 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 122.868 1.26 . . . . 0.0 115.022 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.5 -11.31 61.39 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.08 -1.956 . . . . 0.0 115.259 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -99.28 149.06 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.917 1.859 . . . . 0.0 114.847 -167.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.473 HD13 HG21 ' A' ' 45' ' ' VAL . 9.0 mt -152.34 142.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.894 2.078 . . . . 0.0 110.131 -165.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 62' ' ' THR . 56.8 tt0 -134.31 134.03 41.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 109.0 158.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 79' ' ' LEU . 12.7 ptp -141.86 164.21 30.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.069 1.748 . . . . 0.0 111.21 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.531 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -123.05 150.84 42.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.771 0.828 . . . . 0.0 111.127 171.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.4 mp -149.13 158.99 38.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.572 1.949 . . . . 0.0 110.689 -158.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.93 126.33 11.19 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.586 2.857 . . . . 0.0 110.936 174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.28 140.63 33.6 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.793 2.995 . . . . 0.0 112.928 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.75 -142.63 13.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.522 0.582 . . . . 0.0 111.815 -168.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -109.82 117.22 33.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.981 1.312 . . . . 0.0 110.548 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -127.09 129.14 47.41 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.214 1.006 . . . . 0.0 109.665 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.84 108.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.5 mt -95.69 124.57 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 123.949 0.9 . . . . 0.0 108.899 -171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -107.23 145.31 32.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.668 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.604 HG11 HG11 ' A' ' 33' ' ' VAL . 87.9 t -128.21 90.6 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.467 161.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -122.95 5.9 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -107.36 -14.84 14.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.686 1.195 . . . . 0.0 112.049 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.3 tp -57.3 131.44 50.03 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 108.636 160.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.83 171.23 14.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.935 0.894 . . . . 0.0 112.153 -173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -154.15 136.84 15.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.181 1.392 . . . . 0.0 109.893 166.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.09 120.87 18.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.504 0.722 . . . . 0.0 110.018 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -114.25 107.47 15.64 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.528 1.131 . . . . 0.0 110.288 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -71.94 98.7 2.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.452 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 128.62 34.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.599 1.96 . . . . 0.0 111.281 -167.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.63 139.81 49.76 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.514 1.526 . . . . 0.0 111.174 177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.353 0 CA-C-O 116.766 -2.13 . . . . 0.0 110.146 -170.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.749 0.309 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t 50.19 -151.88 0.18 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.783 1.633 . . . . 0.0 114.414 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -65.14 28.99 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 131.058 3.743 . . . . 0.0 115.19 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -30.73 100.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.645 3.497 . . . . 0.0 116.545 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tp -55.57 -18.94 8.59 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.1 2.16 . . . . 0.0 114.233 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.6 p -99.8 -11.91 20.37 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.488 1.915 . . . . 0.0 114.148 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -73.4 152.35 40.85 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.851 1.205 . . . . 0.0 114.189 -168.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 m -65.64 148.33 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.795 2.038 . . . . 0.0 111.256 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 mmt -60.81 137.86 58.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.931 0.892 . . . . 0.0 111.808 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 36.1 m -66.69 157.1 33.49 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.203 0.525 . . . . 0.0 111.811 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -63.41 121.87 14.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.459 1.504 . . . . 0.0 111.184 171.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -55.26 -19.11 7.45 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.64 -4.29 17.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.522 1.529 . . . . 0.0 115.041 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 43.2 mmtm -105.24 12.88 31.35 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -93.89 158.24 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -139.5 147.05 40.74 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.285 1.834 . . . . 0.0 110.198 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -71.83 107.36 4.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.386 1.074 . . . . 0.0 110.94 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 14.1 ttmt -71.75 -33.88 69.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 110.214 167.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -151.6 111.13 3.98 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.007 2.923 . . . . 0.0 108.051 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.33 152.06 80.48 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 118.372 0.533 . . . . 0.0 111.304 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.3 121.65 8.75 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.041 3.161 . . . . 0.0 114.794 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -137.84 159.94 40.63 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.977 1.711 . . . . 0.0 110.74 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.2 141.41 50.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 162.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -78.75 -11.59 59.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.855 1.662 . . . . 0.0 114.352 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.39 -0.3 58.38 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.392 1.473 . . . . 0.0 113.075 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -130.01 11.7 5.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.591 1.557 . . . . 0.0 112.756 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 69.22 2.33 3.61 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.742 1.617 . . . . 0.0 113.154 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 53.5 p -83.78 162.05 20.75 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.404 1.481 . . . . 0.0 109.532 158.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 79' ' ' LEU . 16.0 t -121.16 115.35 46.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.122 1.769 . . . . 0.0 108.769 -168.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -106.76 144.2 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.516 1.126 . . . . 0.0 110.604 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.407 ' HG2' ' HB ' ' A' ' 75' ' ' ILE . 5.4 ptp -152.4 166.66 31.19 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.394 1.078 . . . . 0.0 109.903 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -152.89 143.86 22.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' H ' ' A' ' 18' ' ' LYS . 11.6 m -134.61 159.67 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.26 153.54 38.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.323 1.849 . . . . 0.0 108.988 166.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 14' ' ' LYS . 57.5 t80 -144.02 114.47 7.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.296 0.639 . . . . 0.0 112.216 -161.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -75.25 3.17 9.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.119 1.768 . . . . 0.0 115.13 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 -149.71 23.52 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.439 1.018 . . . . 0.0 113.854 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -49.93 161.91 0.22 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.817 2.447 . . . . 0.0 115.146 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -143.83 120.86 6.62 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.343 1.857 . . . . 0.0 109.416 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -82.29 167.39 68.14 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.378 1.171 . . . . 0.0 111.0 1.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.6 p -152.22 156.44 39.73 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.04 0.536 . . . . 0.0 110.931 159.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -84.11 127.76 34.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 126.476 1.911 . . . . 0.0 109.413 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.2 mt -68.73 117.12 47.76 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.63 80.28 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.173 3.248 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -111.31 144.43 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 C-N-CA 124.646 1.178 . . . . 0.0 111.892 -167.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -162.4 163.83 27.56 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.537 1.935 . . . . 0.0 108.584 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.02 125.25 31.02 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 108.515 166.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 m -119.97 117.63 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.439 0.638 . . . . 0.0 109.654 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.87 154.34 39.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.384 0.674 . . . . 0.0 112.322 -170.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -50.78 94.09 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.261 1.824 . . . . 0.0 113.23 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.44 -11.82 7.54 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 117.868 -1.518 . . . . 0.0 115.533 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.68 84.84 11.86 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 120.038 1.919 . . . . 0.0 112.985 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.62 -18.55 26.59 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.048 3.166 . . . . 0.0 115.054 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.74 -24.4 53.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.498 2.719 . . . . 0.0 113.368 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -107.93 101.61 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -67.27 123.42 20.29 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.186 166.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.56 5.71 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.837 2.055 . . . . 0.0 112.479 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.97 90.88 0.45 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.95 1.3 . . . . 0.0 113.384 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 68.8 mtm -78.66 87.49 4.58 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.792 -1.193 . . . . 0.0 110.125 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.7 mt -52.34 117.68 3.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.254 1.822 . . . . 0.0 112.424 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.4 mm -87.38 -24.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.592 1.557 . . . . 0.0 110.78 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 76' ' ' GLU . 1.5 t -110.14 153.42 43.27 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.428 1.091 . . . . 0.0 110.509 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.37 162.13 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.332 2.021 . . . . 0.0 115.116 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -19.69 97.55 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 130.56 3.544 . . . . 0.0 114.723 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.0 141.8 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.165 1.91 . . . . 0.0 113.354 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.8 p -133.02 157.89 44.08 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.275 1.43 . . . . 0.0 111.593 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.97 113.39 26.54 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 160.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.86 154.89 29.97 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.904 1.682 . . . . 0.0 110.472 -156.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.39 -27.56 66.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.67 34.81 2.01 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.074 1.35 . . . . 0.0 110.746 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.61 -167.08 40.25 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 121.41 -0.806 . . . . 0.0 113.796 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.81 -173.35 29.32 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 123.565 1.647 . . . . 0.0 115.841 164.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.32 -16.2 59.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 117.482 -1.732 . . . . 0.0 114.638 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -99.14 140.16 33.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.676 1.738 . . . . 0.0 114.509 -167.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 31' ' ' MET . 5.4 mt -142.49 145.71 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.653 1.581 . . . . 0.0 109.953 -170.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 62' ' ' THR . 71.2 tt0 -134.98 132.81 38.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.625 1.57 . . . . 0.0 109.546 164.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 79' ' ' LEU . 17.1 ptp -140.65 167.76 21.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.073 1.749 . . . . 0.0 110.818 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.567 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.1 tt0 -128.3 153.63 46.79 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.622 0.769 . . . . 0.0 110.621 167.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 78' ' ' GLN . 6.1 mp -145.57 161.69 39.8 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.758 1.623 . . . . 0.0 110.793 -160.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.76 129.31 18.42 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.245 2.63 . . . . 0.0 110.931 171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.41 126.63 10.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.513 3.475 . . . . 0.0 113.409 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.47 -176.0 19.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.199 0.904 . . . . 0.0 113.549 -170.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -72.82 119.65 17.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.138 0.975 . . . . 0.0 111.517 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -127.89 118.31 23.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.635 1.574 . . . . 0.0 108.887 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.24 97.45 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.53 135.14 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 123.467 0.707 . . . . 0.0 109.112 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -123.37 141.36 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.773 1.629 . . . . 0.0 111.505 -167.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 45' ' ' VAL . 47.0 t -125.48 98.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 161.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.28 -114.47 4.72 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -114.66 -5.32 12.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 117.585 0.693 . . . . 0.0 112.743 168.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.7 tp -64.58 133.06 51.52 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 160.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -140.28 172.1 13.22 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -159.08 129.03 5.69 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.329 1.851 . . . . 0.0 110.724 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -69.55 107.93 3.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.319 0.648 . . . . 0.0 110.265 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -97.18 116.47 29.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.823 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.7 87.2 6.32 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.878 1.271 . . . . 0.0 110.116 170.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -68.29 140.37 55.96 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.704 1.202 . . . . 0.0 112.163 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -118.02 165.21 14.0 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.964 1.306 . . . . 0.0 110.94 161.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 C-N-CA 126.911 2.196 . . . . 0.0 110.713 -173.884 . . . . . . . . 0 0 . 1 stop_ save_